The genetics of obesity and the metabolic syndrome

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 10, Issue 2, 2010, Pages 86-108

  Monda, Keri L ^a   North, Kari E ^a   Hunt, Steven C ^b   Rao, D C ^c   Province, Michael A ^d   Kraja, Aldi T ^d  

^a Carolina Center for Genome Sciences   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Common complex disease; Genetics; GWAS; Metabolic syndrome; Obesity

Indexed keywords

ACYL COENZYME A DESATURASE 1; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; APOLIPOPROTEIN A1; CADHERIN; CHOLESTEROL ESTER TRANSFER PROTEIN; CRYPTOCHROME 2; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; GLUCOCORTICOID RECEPTOR; GLUCOSE; GLUCOSE TRANSPORTER 2; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LEPTIN; MELANOCORTIN 4 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUREXIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; POTASSIUM CHANNEL KCNQ1; RESISTIN; SOMATOMEDIN B; SOMATOMEDIN C; TRANSCRIPTION FACTOR 7 LIKE 2; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FATTY LIVER; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENETICS; GLUCOSE BLOOD LEVEL; HEART VENTRICLE HYPERTROPHY; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PLEIOTROPY; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 77954068415     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153010791213100     Document Type: Article

References (203)

1. Ogden, C.L.; Carroll, M.D.; Curtin, L.R.; McDowell, M.A.; Tabak, C.J. and Flegal, K.M. (2006) Prevalence of overweight and obesityin the United States, 1999-2004 JAMA, 295(13), 1549-1555.
2. Calle, E.E.; Rodriguez, C.; Walker-Thurmond, K. and Thun, M.J.(2003) Overweight, obesity, and mortality from cancer in a pro-spectively studied cohort of U.S. adults. N. Engl. J. Med., 348(17),1625-1638.
3. Gregg, E.W.; Cheng, Y.J.; Cadwell, B.L.; Imperatore, G.; Wil-liams, D.E.; Flegal, K.M.; Narayan, K.M. and Williamson, D.F.(2005) Secular trends in cardiovascular disease risk factors accord-ing to body mass index in US adults. JAMA, 293(15), 1868-1874.
4. Kopelman, P.G. (2000) Obesity as a medical problem. Nature,404(6778), 635-643.
5. Mendez, M.A.; Monteiro, C.A. and Popkin, B.M. (2005) Over-weight exceeds underweight among women in most developingcountries. Am. J. Clin. Nutr., 81(3), 714-721.
6. Popkin, B.M. (2002) The shift in stages of the nutrition transition inthe developing world differs from past experiences. Public HealthNutr., 5(1A), 205-214.
7. Adair, L.S. (2004) Dramatic rise in overweight and obesity in adultfilipino women and risk of hypertension. Obes. Res., 12(8), 1335-1341.
8. Wang, H.; Du, S.; Zhai, F. and Popkin, B.M. (2007) Trends in thedistribution of body mass index among Chinese adults, aged 20-45years (1989-2000). Int. J. Obes. (Lond), 31(2), 272-278.
9. Brown, C.D.; Higgins, M.; Donato, K.A.; Rohde, F.C.; Garrison,R.; Obarzanek, E.; Ernst, N.D. and Horan, M. (2000) Body massindex and the prevalence of hypertension and dyslipidemia. Obes.Res., 8(9), 605-619.
10. Ferrannini, E. and Camastra, S. (1998) Relationship between im-paired glucose tolerance, non-insulin-dependent diabetes mellitusand obesity. Eur. J. Clin. Invest., 28 Suppl 2, 3-6; discussion 6-7.
11. Ford, E.S.; Giles, W.H. and Dietz, W.H. (2002) Prevalence of themetabolic syndrome among US adults: findings from the third Na-tional Health and Nutrition Examination Survey. JAMA, 287(3),356-359.
12. Martins, D.; Tareen, N.; Ogedegbe, G.; Pan, D. and Norris, K.(2008) The relative risk of cardiovascular death among racial andethnic minorities with metabolic syndrome: data from theNHANES-II mortality follow-up. J. Natl. Med. Assoc., 100(5),565-571.
13. Church, T.S.; Thompson, A.M.; Katzmarzyk, P.T.; Sui, X.; Jo-hannsen, N.; Earnest, C.P. and Blair SN. (2009) Metabolic syndrome and diabetes, alone and in combination, as predictors of car-diovascular disease mortality among men. Diabetes Care, 32(7),1289-1294.
14. Alberti, K.G. and Zimmet, P.Z. (1998) Definition, diagnosis andclassification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report ofa WHO consultation. Diabet. Med., 15(7), 539-553.
15. Executive Summary of The Third Report of The National Choles-terol Education Program (NCEP) Expert Panel on Detection,Evaluation, And Treatment of High Blood Cholesterol In Adults(Adult Treatment Panel III). JAMA, 285(19), 2486-2497, 2001.
16. Alberti, K.G.; Zimmet, P. and Shaw, J. (2005) The metabolic syndrome--a new worldwide definition. Lancet, 366(9491), 1059-1062.
17. Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.; Krauss, R.M.; Savage, P.J.; Smith, S.C. Jr.; Spertus, J.A. and Costa, F. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.Circulation, 112(17), 2735-2752.
18. Alberti, K.G.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.; Loria, C.M. and Smith, S.C. Jr. (2009) Harmonizing the metabolic syndrome: a jointinterim statement of the International Diabetes Federation TaskForce on Epidemiology and Prevention; National Heart, Lung, andBlood Institute; American Heart Association; World Heart Federation;International Atherosclerosis Society; and International Associationfor the Study of Obesity. Circulation, 120(16), 1640-1645.
19. Grundy, S.M. (2006) Does a diagnosis of metabolic syndrome havevalue in clinical practice? Am. J. Clin. Nutr., 83(6), 1248-1251.
20. Bayturan, O.; Tuzcu, E.M.; Lavoie, A.; Hu, T.; Wolski, K.; Schoenhagen, P.; Kapadia, S.; Nissen, S.E. and Nicholls, S.J.(2010) The metabolic syndrome, its component risk factors, andprogression of coronary atherosclerosis. Arch. Intern. Med., 170(5),478-484.
21. Reaven, G.M. (2006) The metabolic syndrome: is this diagnosisnecessary? Am. J. Clin. Nutr., 83(6), 1237-1247.
22. Ervin, R.B. (2009) Prevalence of metabolic syndrome amongadults 20 years of age and over, by sex, age, race and ethnicity, andbody mass index: United States, 2003-2006. Natl. Health Stat.Rep., 13, 1-7.
23. Brown, T.M.; Voeks, J.H.; Bittner, V. and Safford, M.M. (2010)Variations in prevalent cardiovascular disease and future risk bymetabolic syndrome classification in the REasons for Geographicand Racial Differences in Stroke (REGARDS) study. Am. Heart J.,159(3), 385-391.
24. Voulgari, C.; Moyssakis, I.; Papazafiropoulou, A.; Perrea, D.; Kyriaki, D.; Katsilambros, N. and Tentolouris, N. (2010) The impactof metabolic syndrome on left ventricular myocardial performance.Diabetes Metab. Res. Rev., 26(2), 121-127.
25. Ballantyne, C.M.; Hoogeveen, R.C.; McNeill, A.M.; Heiss, G.; Schmidt, M.I.; Duncan, B.B. and Pankow, J.S. (2008) Metabolicsyndrome risk for cardiovascular disease and diabetes in the ARICstudy. Int. J. Obes. (Lond), 32(Suppl 2),S21-S24.
26. Ninomiya, J.K.; L'Italien, G.; Criqui, M.H.; Whyte, J.L.; Gamst, A. and Chen, R.S. (2004) Association of the metabolic syndrome withhistory of myocardial infarction and stroke in the Third NationalHealth and Nutrition Examination Survey. Circulation, 109(1), 42-46.
27. Lakka, H.M.; Laaksonen, D.E.; Lakka, T.A.; Niskanen, L.K.; Kumpusalo, E.; Tuomilehto, J. and Salonen, J.T. (2002) The metabolicsyndrome and total and cardiovascular disease mortality inmiddle-aged men JAMA, 288(21), 2709-2716.
28. Rankinen, T.; Zuberi, A.; Chagnon, Y.C.; Weisnagel, S.J.; Argyropoulos, G.; Walts, B.; Perusse, L. and Bouchard, C. (2006) Thehuman obesity gene map: the 2005 update. Obesity (Silver Spring),14(4), 529-644.
29. Lyon, H.N. and Hirschhorn, J.N. (2005) Genetics of commonforms of obesity: a brief overview. Am. J. Clin. Nutr., 82(1 Suppl),215S-217S.
30. Loos, R.J. and Bouchard, C. (2003)Obesity--is it a genetic disorder?J. Intern. Med., 254(5), 401-425.
31. Frayling, T.M.; Timpson, N.J.; Weedon, M.N.; Zeggini, E.; Freathy, R.M.; Lindgren, C.M.; Perry, J.R.; Elliott, K.S.; Lango, H.; Rayner, N.W.; Shields, B.; Harries, L.W.; Barrett, J.C.; Ellard, S.; Groves, C.J.; Knight, B.; Patch, A.M.; Ness, A.R.; Ebrahim, S.; Lawlor, D.A.; Ring, S.M.; Ben-Shlomo, Y.; Jarvelin, M.R.; Sovio, U.; Bennett, A.J.; Melzer, D.; Ferrucci, L.; Loos, R.J.; Barroso, I.; Wareham, N.J.; Karpe, F.; Owen, K.R.; Cardon, L.R.; Walker, M.; Hitman, G.A.; Palmer, C.N.; Doney, A.S.; Morris, A.D.; Smith, G.D.; Hattersley, A.T. and McCarthy, M.I. (2007) A common variantin the FTO gene is associated with body mass index and predisposesto childhood and adult obesity. Science, 316(5826), 889-894.
32. Scuteri, A.; Sanna, S.; Chen, W.M.; Uda, M.; Albai, G.; Strait, J.; Najjar, S.; Nagaraja, R.; Orru, M.; Usala, G.; Dei, M.; Lai, S.; Maschio, A.; Busonero, F.; Mulas, A.; Ehret, G.B.; Fink, A.A.; Weder, A.B.; Cooper, R.S.; Galan, P.; Chakravarti, A.; Schlessinger, D.; Cao, A.; Lakatta, E. and Abecasis, G.R. (2007) Genomewideassociation scan shows genetic variants in the FTO gene areassociated with obesity-related traits. PLoS Genet., 3(7), e115.
33. Loos, R.J.; Lindgren, C.M.; Li, S.; Wheeler, E.; Zhao, J.H.; Prokopenko, I.; Inouye, M.; Freathy, R.M.; Attwood, A.P.; Beckmann, J.S.; Berndt, S.I.; Jacobs, K.B.; Chanock, S.J.; Hayes, R.B.; Bergmann, S.; Bennett, A.J.; Bingham, S.A.; Bochud, M.; Brown, M.; Cauchi, S.; Connell, J.M.; Cooper, C.; Smith, G.D.; Day, I.; Dina, C.; De, S.; Dermitzakis, E.T.; Doney, A.S.; Elliott, K.S.; Elliott, P.; Evans, D.M.; Sadaf, F.I.; Froguel, P.; Ghori, J.; Groves, C.J.; Gwilliam, R.; Hadley, D.; Hall, A.S.; Hattersley, A.T.; Hebebrand, J.; Heid, I.M.; Lamina, C.; Gieger, C.; Illig, T.; Meitinger, T.; Wichmann, H.E.; Herrera, B.; Hinney, A.; Hunt, S.E.; Jarvelin, M.R.; Johnson, T.; Jolley, J.D.; Karpe, F.; Keniry, A.; Khaw, K.T.; Luben, R.N.; Mangino, M.; Marchini, J.; McArdle, W.L.; McGinnis, R.; Meyre, D.; Munroe, P.B.; Morris, A.D.; Ness, A.R.; Neville, M.J.; Nica, A.C.; Ong, K.K.; O'Rahilly, S.; Owen, K.R.; Palmer, C.N.; Papadakis, K.; Potter, S.; Pouta, A.; Qi, L.; Randall, J.C.; Rayner, N.W.; Ring, S.M.; Sandhu, M.S.; Scherag, A.; Sims, M.A.; Song, K.; Soranzo, N.; Speliotes, E.K.; Syddall, H.E.;Teichmann, S.A.; Timpson, N.J.; Tobias, J.H.; Uda, M.; Vogel, C.I.; Wallace, C.; Waterworth, D.M.; Weedon, M.N.; Willer, C.J.; Wraight Yuan, X.; Zeggini, E.; Hirschhorn, J.N.; Strachan, D.P.; Ouwehand, W.H.; Caulfield, M.J.; Samani, N.J.; Frayling, T.M.; Vollenweider, P.; Waeber, G.; Mooser, V.; Deloukas, P.; McCarthy, M.I.; Wareham, N.J.; Barroso, I.; Kraft, P.; Hankinson, S.E.; Hunter, D.J.; Hu, F.B.; Lyon, H.N.; Voight, B.F.; Ridderstrale, M.; Groop, L.; Scheet, P.; Sanna, S.; Abecasis, G.R.; Albai, G.; Nagaraja, R.; Schlessinger, D.; Jackson, A.U.; Tuomilehto, J.; Collins, F.S.; Boehnke, M. and Mohlke, K.L. (2008) Commonvariants near MC4R are associated with fat mass, weight and riskof obesity. Nat. Genet., 40(6), 768-775.
34. Chambers, J.C.; Elliott, P.; Zabaneh, D.; Zhang, W.; Li, Y.;Froguel, P.; Balding, D.; Scott, J. and Kooner, J.S. (2008) Commongenetic variation near MC4R is associated with waist circumferenceand insulin resistance. Nat. Genet., 40(6), 716-718.
35. Heard-Costa, N.L.; Zillikens, M.C.; Monda, K.L.; Johansson, A.; Harris, T.B.; Fu, M.; Haritunians, T.; Feitosa, M.F.; Aspelund, T.; Eiriksdottir, G.; Garcia, M.; Launer, L.J.; Smith, A.V.; Mitchell, B.D.; McArdle, P.F.; Shuldiner, A.R.; Bielinski, S.J.; Boerwinkle, E.; Brancati, F.; Demerath, E.W.; Pankow, J.S.; Arnold, A.M.; Chen, Y.D.; Glazer, N.L.; McKnight, B.; Psaty, B.M.; Rotter, J.I.; Amin, N.; Campbell, H.; Gyllensten, U.; Pattaro, C.; Pramstaller, P.P.; Rudan, I.; Struchalin, M.; Vitart, V.; Gao, X.; Kraja, A.; Province, M.A.; Zhang, Q.; Atwood, L.D.; Dupuis, J.; Hirschhorn, J.N.; Jaquish, C.E.; O'Donnell, C.J.; Vasan, R.S.; White, C.C.; Aulchenko, Y.S.; Estrada, K.; Hofman, A.; Rivadeneira, F.; Uitterlinden, A.G.; Witteman, J.C.; Oostra, B.A.; Kaplan, R.C.; Gudnason, V.; O'Connell, J.R.; Borecki, I.B.; van Duijn, C.M.; Cupples, L.A.; Fox, C.S. and North, K.E. (2009) NRXN3 is a novel locus for waistcircumference: a genome-wide association study from theCHARGE Consortium. PLoS Genet., 5(6), e1000539.
36. Meyre, D.; Delplanque, J.; Chevre, J.C.; Lecoeur, C.; Lobbens, S.; Gallina, S.; Durand, E.; Vatin, V.; Degraeve, F.; Proenca, C.; Gaget, S.; Korner, A.; Kovacs, P.; Kiess, W.; Tichet, J.; Marre, M.; Hartikainen, A.L.; Horber, F.; Potoczna, N.; Hercberg, S.; Levy-Marchal, C.; Pattou, F.; Heude, B.; Tauber, M.; McCarthy, M.I.; Blakemore, A.I.; Montpetit, A.; Polychronakos, C.; Weill, J.; Coin, L.J.; Asher, J.; Elliott, P.; Jarvelin, M.R.; Visvikis-Siest, S.; Balkau, B.; Sladek, R.; Balding, D.; Walley, A.; Dina, C. and Froguel, P. (2009) Genome-wide association study for early-onset and morbidadult obesity identifies three new risk loci in European populations.Nat. Genet., 41(2), 157-159.
37. Thorleifsson, G.; Walters, G.B.; Gudbjartsson, D.F.; Steinthorsdottir, V.; Sulem, P.; Helgadottir, A.; Styrkarsdottir, U.; Gretarsdottir, S.; Thorlacius, S.; Jonsdottir, I.; Jonsdottir, T.; Olafsdottir, E.J.; Olafsdottir, G.H.; Jonsson, T.; Jonsson, F.; Borch-Johnsen, K.; Hansen, T.; Andersen, G.; Jorgensen, T.; Lauritzen, T.; Aben, K.K.; Verbeek, A.L.; Roeleveld, N.; Kampman, E.; Yanek, L.R.; Becker, L.C.; Tryggvadottir, L.; Rafnar, T.; Becker, D.M.; Gulcher, J.; Kiemeney, L.A.; Pedersen, O.; Kong, A.; Thorsteinsdottir, U. and Stefansson, K. (2009) Genome-wide association yields new sequencevariants at seven loci that associate with measures of obesity.Nat. Genet., 41(1), 18-24.
38. Willer, C.J.; Speliotes, E.K.; Loos, R.J.; Li, S.; Lindgren, C.M.; Heid, I.M.; Berndt, S.I.; Elliott, A.L.; Jackson, A.U.; Lamina, C.; Lettre, G.; Lim, N.; Lyon, H.N.; McCarroll, S.A.; Papadakis, K.; Qi, L.; Randall, J.C.; Roccasecca, R.M.; Sanna, S.; Scheet, P.; Weedon, M.N.; Wheeler, E.; Zhao, J.H.; Jacobs, L.C.; Prokopenko, I.; Soranzo, N.; Tanaka, T.; Timpson, N.J.; Almgren, P.; Bennett A, Bergman, R.N.; Bingham, S.A.; Bonnycastle, L.L.; Brown, M.; Burtt, N.P.; Chines, P.; Coin, L.; Collins, F.S.; Connell, J.M.; Cooper, C.; Smith, G.D.; Dennison, E.M.; Deodhar, P.; Elliott, P.; Erdos, M.R.; Estrada, K.; Evans, D.M.; Gianniny, L.; Gieger, C.; Gillson, C.J.; Guiducci, C.; Hackett, R.; Hadley, D.; Hall, A.S.; Havulinna, A.S.; Hebebrand, J.; Hofman, A.; Isomaa, B.; Jacobs, K.B.; Johnson, T.; Jousilahti, P.; Jovanovic, Z.; Khaw, K.T.; Kraft, P.; Kuokkanen, M.; Kuusisto, J.; Laitinen, J.; Lakatta, E.G.; Luan, J.; Luben, R.N.; Mangino, M.; McArdle, W.L.; Meitinger, T.; Mulas, A.; Munroe, P.B.; Narisu, N.; Ness, A.R.; Northstone, K.; O'Rahilly, S.; Purmann, C.; Rees, M.G.; Ridderstrale, M.; Ring, S.M.; Rivadeneira, F.; Ruokonen, A.; Sandhu, M.S.; Saramies, J.; Scott, L.J.; Scuteri, A.; Silander, K.; Sims, M.A.; Song, K.; Stephens, J.; Stevens, S.; Stringham, H.M.; Tung, Y.C.; Valle, T.T.; Van Duijn, C.M.; Vimaleswaran, K.S.; Vollenweider, P.; Waeber, G.; Wallace, C.; Watanabe, R.M.; Waterworth, D.M.; Watkins, N.; Witteman, J.C.; Zeggini, E.; Zhai, G.; Zillikens, M.C.; Altshuler, D.; Caulfield, M.J.; Chanock, S.J.; Farooqi, I.S.; Ferrucci, L.; Guralnik, J.M.; Hattersley, A.T.; Hu, F.B.; Jarvelin, M.R.; Laakso, M.; Mooser, V.; Ong, K.K.; Ouwehand, W.H.; Salomaa, V.; Samani, N.J.; Spector, T.D.; Tuomi, T.; Tuomilehto, J.; Uda, M.; Uitterlinden, A.G.; Wareham, N.J.; Deloukas, P.; Frayling, T.M.; Groop, L.C.; Hayes, R.B.; Hunter, D.J.; Mohlke, K.L.; Peltonen, L.; Schlessinger, D.; Strachan, D.P.; Wichmann, H.E.; McCarthy, M.I.; Boehnke, M.; Barroso, I.; Abecasis, G.R. and Hirschhorn, J.N. (2009) Six new loci associated with body mass index highlighta neuronal influence on body weight regulation. Nat. Genet., 41(1), 25-34.
39. Cotsapas, C.; Speliotes, E.K.; Hatoum, I.J.; Greenawalt, D.M.; Dobrin, R.; Lum, P.Y.; Suver, C.; Chudin, E.; Kemp, D.; Reitman, M.; Voight, B.F.; Neale, B.M.; Schadt, E.E.; Hirschhorn, J.N.; Kaplan, L.M. and Daly, M.J. (2009) Common body mass indexassociatedvariants confer risk of extreme obesity. Hum. Mol.Genet., 18(18), 3502-3507.
40. Lindgren, C.M.; Heid, I.M.; Randall, J.C.; Lamina, C.; Steinthorsdottir, V.; Qi, L.; Speliotes, E.K.; Thorleifsson, G.; Willer, C.J.; Herrera, B.M.; Jackson, A.U.; Lim, N.; Scheet, P.; Soranzo, N.; Amin, N.; Aulchenko, Y.S.; Chambers, J.C.; Drong, A.; Luan, J.; Lyon, H.N.; Rivadeneira, F.; Sanna, S.; Timpson, N.J.; Zillikens, M.C.; Zhao, J.H.; Almgren, P.; Bandinelli, S.; Bennett, A.J.; Bergman, R.N.; Bonnycastle, L.L.; Bumpstead, S.J.; Chanock, S.J.; Cherkas, L.; Chines, P.; Coin, L.; Cooper, C.; Crawford, G.; Doering, A.; Dominiczak, A.; Doney, A.S.; Ebrahim, S.; Elliott, P.; Erdos, M.R.; Estrada, K.; Ferrucci, L.; Fischer, G.; Forouhi, N.G.; Gieger, C.; Grallert, H.; Groves, C.J.; Grundy, S.; Guiducci, C.; H adley, D.; Hamsten, A.; Havulinna, A.S.; Hofman, A.; Holle, R.; Holloway, J.W.; Illig, T.; Isomaa, B.; Jacobs, L.C.; Jameson, K.;Jousilahti, P.; Karpe, F.; Kuusisto, J.; Laitinen, J.; Lathrop, G.M.; Lawlor, D.A.; Mangino, M.; McArdle, W.L.; Meitinger, T.; Morken, M.A.; Morris, A.P.; Munroe, P.; Narisu, N.; Nordstrom, A.; aNordstrom, P.; Oostra, B.A.; Palmer, C.N.; Payne, F.; Peden, J.F.; Prokopenko, I.; Renstrom, F.; Ruokonen, A.; Salomaa, V.; Sandhu, M.S.; Scott, L.J.; Scuteri, A.; Silander, K.; Song, K.; Yuan, X.; Stringham, H.M.; Swift, A.J.; Tuomi, T.; Uda, M.; Vollenweider, P.; Waeber, G.; Wallace, C.; Walters, G.B.; Weedon, M.N.; Witteman, J.C.; Zhang, C.; Zhang, W.; Caulfield, M.J.; Collins, F.S.; Davey, S.G.; Day, I.N.; Franks, P.W.; Hattersley, A.T.; Hu, F.B.; Jarvelin, M.R.; Kong, A.; Kooner, J.S.; Laakso, M.; Lakatta, E.; Mooser, V.; Morris, A.D.; Peltonen, L.; Samani, N.J.; Spector, T.D.; Strachan, D.P.; Tanaka, T.; Tuomilehto, J.; Uitterlinden, A.G.; van Duijn, C.M.; Wareham, N.J.; Hugh, W.; Waterworth, D.M.; Boehnke, M.; Deloukas, P.; Groop, L.; Hunter, D.J.; Thorsteinsdottir, U.; Schlessinger, D.; Wichmann, H.E.; Frayling, T.M.; Abecasis, G.R.; Hirschhorn, J.N.; Loos, R.J.; Stefansson, K.; Mohlke, K.L.; Barroso, I. and McCarthy, M.I. (2009) Genomewideassociation scan meta-analysis identifies three Loci influencingadiposity and fat distribution. PLoS Genet, 5(6), e1000508.
41. Manolio, T.A.; Rodriguez, L.L.; Brooks, L.; Abecasis, G.; Ballinger, D.; Daly, M.; Donnelly, P.; Faraone, S.V.; Frazer, K.; Gabriel, S.; Gejman, P.; Guttmacher, A.; Harris, E.L.; Insel, T.; Kelsoe, J.R.; Lander, E.; McCowin, N.; Mailman, M.D.; Nabel, E.; Ostell, J.; Pugh, E.; Sherry, S.; Sullivan, P.F.; Thompson, J.F.; Warram, J.; Wholley, D.; Milos, P.M. and Collins, F.S. (2007) New models ofcollaboration in genome-wide association studies: the Genetic AssociationInformation Network. Nat. Genet., 39(9), 1045-1051.
42. McCarthy, M.I.; Abecasis, G.R.; Cardon, L.R.; Goldstein, D.B.; Little, J.; Ioannidis, J.P. and Hirschhorn, J.N. (2008) Genome-wideassociation studies for complex traits: consensus, uncertainty andchallenges. Nat. Rev. Genet., 9(5), 356-369.
43. Argyropoulos, G. Genetics of the metabolic syndrome. In: KumarS, O'Rahilly S, Eds. Insulin Resistance. West Essex, England: JohnWiley & Sons, Ltd, 2005, pp. 401-450.
44. Perusse, L.; Despres, J.P.; Tremblay, A.; Leblanc, C.; Talbot, J.; Allard, C. and Bouchard, C. (1989) Genetic and environmental determinantsof serum lipids and lipoproteins in French Canadianfamilies. Arteriosclerosis, 9(3), 308-318.
45. Katzmarzyk, P.T.; Perusse, L.; Rice, T.; Rao, D.C. and Bouchard, C. (2001) Familial aggregation of seven-year changes in bloodpressure in Canada. Can. J. Cardiol., 17(12), 1267-1274.
46. An, P.; Rice, T.; Gagnon, J.; Borecki, I.B.; Perusse, L.; Leon, A.S.; Skinner, J.S.; Wilmore, J.H.; Bouchard, C. and Rao, D.C. (1999)Familial aggregation of resting blood pressure and heart rate in asedentary population: the HERITAGE Family Study. Health, RiskFactors, Exercise Training, and Genetics. Am. J. Hypertens., 12(3),264-270.
47. Rice, T.; Rankinen, T.; Province, M.A.; Chagnon, Y.C.; Perusse, L.; Borecki, I.B.; Bouchard, C.; Rao, D.C. (2000) Genome-widelinkage analysis of systolic and diastolic blood pressure: the QuebecFamily Study. Circulation, 102(16), 1956-1963.
48. Lehtovirta, M.; Kaprio, J.; Forsblom, C.; Eriksson, J.; Tuomilehto, J. and Groop, L. (2000) Insulin sensitivity and insulin secretion inmonozygotic and dizygotic twins. Diabetologia, 43(3), 285-293.
49. Mayer, E.J.; Newman, B.; Austin, M.A.; Zhang, D.; Quesenberry, C.P.Jr.; Edwards, K. and Selby, J.V. (1996) Genetic and environmentalinfluences on insulin levels and the insulin resistance syndrome:an analysis of women twins. Am. J. Epidemiol., 143(4),323-332.
50. Carmelli, D.; Cardon, L.R. and Fabsitz, R. (1994) Clustering ofhypertension, diabetes, and obesity in adult male twins: same genesor same environments? Am. J. Hum. Genet., 55(3), 566-573.
51. Mitchell, B.D.; Kammerer, C.M.; Mahaney, M.C.; Blangero, J.; Comuzzie, A.G.; Atwood, L.D.; Haffner, S.M.; Stern, M.P. and MacCluer, J.W. (1996) Genetic analysis of the IRS. Pleiotropic effectsof genes influencing insulin levels on lipoprotein and obesitymeasures. Arterioscler. Thromb. Vasc. Biol., 16(2), 281-288.
52. Kissebah, A.H.; Sonnenberg, G.E.; Myklebust, J.; Goldstein, M.; Broman, K.; James, R.G.; Marks, J.A.; Krakower, G.R.; Jacob, H.J.; Weber, J.; Martin, L.; Blangero, J. and Comuzzie, A.G.(2000) Quantitative trait loci on chromosomes 3 and 17 influencephenotypes of the metabolic syndrome. Proc. Natl. Acad. Sci. USA,97(26), 14478-14483.
53. Liese, A.D.; Mayer-Davis, E.J.; Tyroler, H.A.; Davis, C.E.; Keil, U.; Schmidt, M.I.; Brancati, F.L. and Heiss, G. (1997) Familialcomponents of the multiple metabolic syndrome: the ARIC Study.Diabetologia 40(8), 963-970
54. Hong, Y.; Rice, T.; Gagnon, J.; Despres, J.P.; Nadeau, A.; Perusse, L.; Bouchard, C.; Leon, A.S.; Skinner, J.S.; Wilmore, J.H. and Rao, D.C. (1998) Familial clustering of insulin and abdominal visceralfat: the HERITAGE Family Study. J. Clin. Endocrinol. Metab.,83(12), 4239-4245.
55. Lehman, D.M.; Arya, R.; Blangero, J.; Almasy, L.; Puppala, S.; Dyer, T.D.; Leach, R.J.; O'Connell, P.; Stern, M.P. and Duggirala, R. (2005) Bivariate linkage analysis of the insulin resistance syndromephenotypes on chromosome 7q. Hum. Biol., 77(2), 231-246.
56. Arya, R.; Lehman, D.; Hunt, K.J.; Schneider, J.; Almasy, L.; Blangero, J.; Stern, M.P. and Duggirala, R. (2003) Evidence for bivariatelinkage of obesity and HDL-C levels in the FraminghamHeart Study. BMC Genet., 4(Suppl 1), S52.
57. Turner, S.T.; Kardia, S.L.; Boerwinkle, E. and Andrade, M.M.(2004) Multivariate linkage analysis of blood pressure and bodymass index. Genet Epidemiol., 27, 64-73.
58. Loos, R.J.; Katzmarzyk, P.T.; Rao, D.C.; Rice, T.; Leon, A.S.; Skinner, J.S.; Wilmore, J.H.; Rankinen, T. and Bouchard, C. (2003)Genome-wide linkage scan for the metabolic syndrome in theHERITAGE Family Study. J. Clin. Endocrinol. Metab., 88(12),5935-5943.
59. Kraja, A.T.; Hunt, S.C.; Pankow, J.S.; Myers, R.H.; Heiss, G.; Lewis, C.E.; Rao, D.C. and Province, M.A. (2005) Quantitativetrait loci for metabolic syndrome in the Hypertension Genetic EpidemiologyNetwork study. Obes. Res., 13(11), 1885-1890.
60. Kraja, A.T.; Rao, D.C.; Weder, A.B.; Cooper, R.; Curb, J.D.; Hanis, C.L.; Turner, S.T.; de Andrade, M.; Hsiung, C.A.; Quertermous, T.; Zhu, X. and Province, M.A. (2005) Two majorQTLs and several others relate to factors of metabolic syndrome inthe family blood pressure program. Hypertension, 46(4), 751-757.
61. Park, Y.M.; Province, M.A.; Gao, X.; Feitosa, M.; Wu, J.; Ma, D.; Rao, D. and Kraja, A.T. (2009) Longitudinal trends in the associationof metabolic syndrome with 550 k single-nucleotide polymorphismsin the Framingham Heart Study. BMC Proc., 3 (Suppl 7),S116.
62. Pirruccello, J. and Kathiresan, S. (2010) Genetics of lipid disorders.Curr. Opin. Cardiol.,[Epub ahead of Print].
63. Dupuis, J.; Langenberg, C.; Prokopenko, I.; Saxena, R.; Soranzo, N.; Jackson, A.U.; Wheeler, E.; Glazer, N.L.; Bouatia-Naji, N.; Gloyn, A.L.; Lindgren, C.M.; Magi, R.; Morris, A.P.; Randall, J.; Johnson, T.; Elliott, P.; Rybin, D.; Thorleifsson, G.; Steinthorsdottir, V.; Henneman, P.; Grallert, H.; Dehghan, A.; Hottenga, J.J.; Franklin, C.S.; Navarro, P.; Song, K.; Goel, A.; Perry, J.R.; Egan, J.M.; Lajunen, T.; Grarup, N.; Sparso, T.; Doney, A.; Voight, B.F.; Stringham, H.M.; Li, M.; Kanoni, S.; Shrader, P.; Cavalcanti-Proenca, C.; Kumari, M.; Qi, L.; Timpson, N.J.; Gieger, C.; Zabena, C.; Rocheleau, G.; Ingelsson, E.; An, P.; O'Connell, J.; Luan, J.; Elliott, A.; McCarroll, S.A.; Payne, F.; Roccasecca, R.M.; Pattou, F.; Sethupathy, P.; Ardlie, K.; Ariyurek, Y.; Balkau, B.; Barter, P.; Beilby, J.P.; Ben-Shlomo, Y.; Benediktsson, R.; Bennett, A.J.; Bergmann, S.; Bochud, M.; Boerwinkle, E.; Bonnefond, A.; Bonnycastle, L.L.; Borch-Johnsen, K.; Bottcher, Y.; Brunner, E.; Bumpstead, S.J.; Charpentier, G.; Chen, Y.D.; Chines, P.; Clarke, R.; Coin, L.J.; Cooper, M.N.; Cornelis, M.; Crawford, G.; Crisponi, L.; Day, I.N.; de Geus, E.J.; Delplanque, J.; Dina, C.; Erdos, M.R.; Fedson, A.C.; Fischer-Rosinsky, A.; Forouhi, N.G.; Fox, C.S.; Frants, R.; Franzosi, M.G.; Galan, P.; Goodarzi, M.O.; Graessler, J.; Groves, C.J.; Grundy, S.; Gwilliam, R.; et al.(2010) New geneticloci implicated in fasting glucose homeostasis and their impact ontype 2 diabetes risk. Nat. Genet., 42(2), 105-116.
64. Zeggini, E.; Scott, L.J.; Saxena, R.; Voight, B.F.; Marchini, J.L.; Hu, T.; de Bakker, P.I.; Abecasis, G.R.; Almgren, P.; Andersen, G.; Ardlie, K.; Bostrom, K.B.; Bergman, R.N.; Bonnycastle, L.L.; Borch-Johnsen, K.; Burtt, N.P.; Chen, H.; Chines, P.S.; Daly, M.J.; Deodhar, P.; Ding, C.J.; Doney, A.S.; Duren, W.L.; Elliott, K.S.; Erdos, M.R.; Frayling, T.M.; Freathy, R.M.; Gianniny, L.; Grallert, H.; Grarup, N.; Groves, C.J.; Guiducci, C.; Hansen, T.; Herder, C.; Hitman, G.A.; Hughes, T.E.; Isomaa, B.; Jackson, A.U.; Jorgensen, T.; Kong, A.; Kubalanza, K.; Kuruvilla, F.G.; Kuusisto, J.; Langenberg, C.; Lango, H.; Lauritzen, T.; Li, Y.; Lindgren, C.M.; Lyssenko, V.; Marvelle, A.F.; Meisinger, C.; Midthjell, K.; Mohlke, K.L.; Morken, M.A.; Morris, A.D.; Narisu, N.; Nilsson, P.; Owen, K.R.; Palmer, C.N.; Payne, F.; Perry, J.R.; Pettersen, E.; Platou, C.; Prokopenko, I.; Qi, L.; Qin, L.; Rayner, N.W.; Rees, M.; Roix, J.J.; Sandbaek, A.; Shields, B.; Sjogren, M.; Steinthorsdottir, V.; Stringham, H.M.; Swift, A.J.; Thorleifsson, G.; Thorsteinsdottir, U.; Timpson, N.J.; Tuomi, T.; Tuomilehto, J.; Walker, M.; Watanabe, R.M.; Weedon, M.N.; Willer, C.J.; Illig, T.; Hveem, K.; Hu, F.B.; Laakso, M.; Stefansson, K.; Pedersen, O.; Wareham, N.J.; Barroso, I.; Hattersley, A.T.; Collins, F.S.; Groop, L.; McCarthy, M.I.; Boehnke, M. and Altshuler, D. Meta-analysis ofgenome-wide association data and large-scale replication identifiesadditional susceptibility loci for type 2 diabetes. Nat. Genet., 40(5),638-645.
65. Kathiresan, S.; Willer, C.J.; Peloso, G.M.; Demissie, S.; Musunuru, K.; Schadt, E.E.; Kaplan, L.; Bennett, D.; Li, Y.; Tanaka, T.; Voight, B.F.; Bonnycastle, L.L.; Jackson, A.U.; Crawford, G.; Surti, A.; Guiducci, C.; Burtt, N.P.; Parish, S.; Clarke, R.; Zelenika, D.; Kubalanza, K.A.; Morken, M.A.; Scott, L.J.; Stringham, H.M.; Galan, P.; Swift, A.J.; Kuusisto, J.; Bergman, R.N.; Sundvall, J.; Laakso, M.; Ferrucci, L.; Scheet, P.; Sanna, S.; Uda, M.; Yang, Q.; Lunetta, K.L.; Dupuis, J.; de Bakker, P.I.; O'Donnell, C.J.; Chambers, J.C.; Kooner, J.S.; Hercberg, S.; Meneton, P.; Lakatta, E.G.; Scuteri, A.; Schlessinger, D.; Tuomilehto, J.; Collins, F.S.; Groop, L.; Altshuler, D.; Collins, R.; Lathrop, G.M.; Melander, O.; Salomaa, V.; Peltonen, L.; Orho-Melander, M.; Ordovas, J.M.; Boehnke, M.; Abecasis, G.R.; Mohlke, K.L. and Cupples, L.A.(2006) Common variants at 30 loci contribute to polygenic dyslipidemia.Nat. Genet., 41(1), 56-65.
66. Reaven, G.M. (1988) Banting lecture 1988. Role of insulin resistancein human disease. Diabetes, 37(12), 1595-1607.
67. Haffner, S.M.; Valdez, R.A.; Hazuda, H.P.; Mitchell, B.D.;Morales, P.A. and Stern, M.P. (1992) Prospective analysis of theinsulin-resistance syndrome (syndrome X). Diabetes, 41(6), 715-722.
68. Gade, W.; Schmit, J.; Collins, M. and Gade, J. (2010) Beyondobesity: the diagnosis and pathophysiology of metabolic syndrome.Clin. Lab. Sci., 23(1), 51-61; quiz 62-5.
69. Ascaso, J.F.; Romero, P.; Real, J.T.; Lorente, R.I.; Marti nez-Valls,J. and Carmena, R. (2003) Abdominal obesity, insulin resistance,and metabolic syndrome in a southern European population. Eur. J.Intern. Med., 14(2), 101-106.
70. Haffner, S.M.; Mykkanen, L.; Rainwater, D.L.; Karhapaa, P. and Laakso, M. (1999) Is leptin concentration associated with the insulinresistance syndrome in nondiabetic men? Obes. Res., 7(2), 164-169.
71. Alexander, C.M.; Landsman, P.B. and Grundy, S.M. (2008) Theinfluence of age and body mass index on the metabolic syndromeand its components. Diabetes Obes. Metab., 10(3), 246-250.
72. Chang, C.; Garcia-Garcia, A.B.; Hamilton, E.; Shah, B.; Meguro,S.; Grundy, S.M.; Provost, D. and Vega, G.L. (2000) Metabolicsyndrome phenotype in very obese women. Metab. Syndr. Relat.Disord., 5(1), 3-12.
73. Grundy, S.M. (2000) Metabolic complications of obesity. Endocrine,13(2), 155-165.
74. Grundy, S.M. (2002) Obesity, metabolic syndrome, and coronaryatherosclerosis. Circulation, 105(23), 2696-2698.
75. Grundy, S.M. (2004) What is the contribution of obesity to themetabolic syndrome? Endocrinol. Metab. Clin. North Am., 33(2),267-82.
76. Grundy, S.M. (2007) Metabolic syndrome: a multiplex cardiovascularrisk factor. J. Clin. Endocrinol. Metab., 92(2), 399-404.
77. Grundy, S.M. (2008) Metabolic syndrome pandemic. Arterioscler.Thromb. Vasc. Biol., 28(4), 629-636.
78. Haffner, S. and Taegtmeyer, H. (2003) Epidemic obesity and themetabolic syndrome. Circulation, 108(13), 1541-1545.
79. Haffner, S.M. (2000) Obesity and the metabolic syndrome: the SanAntonio Heart Study. Br. J. Nutr., 83(Suppl 1), S67-S70.
80. Haffner, S.M. (2006) Relationship of metabolic risk factors anddevelopment of cardiovascular disease and diabetes. Obesity (SilverSpring), 14(Suppl 3), 121S-127S.
81. Lorenzo, C.; Serrano-Rios, M.; Martinez-Larrad, M.T.; Gonzalez-Villalpando, C.; Gonzalez-Sanchez, J.L.; Martinez-Calatrava, M.J.; Gabriel, R. and Haffner, S.M. (2007) Is waist circumference an essentialcomponent of the metabolic syndrome? Diabetes Care,30(8), 2141-2142.
82. Pladevall, M.; Singal, B.; Williams, L.K.; Brotons, C.; Guyer, H.; Sadurni, J.; Falces, C.; Serrano-Rios, M.; Gabriel, R.; Shaw, J.E.; Zimmet, P.Z. and Haffner, S. (2006) A single factor underlies themetabolic syndrome: a confirmatory factor analysis. DiabetesCare, 29(1), 113-122.
83. Stancakova, A.; Javorsky, M.; Kuulasmaa, T.; Haffner, S.M.; Kuusisto, J. and Laakso, M. (2009) Changes in insulin sensitivityand insulin release in relation to glycemia and glucose tolerance in6,414 Finnish men. Diabetes, 58(5), 1212-1221.
84. Vega, G.L.; Adams-Huet, B.; Peshock, R.; Willett, D.; Shah, B. and Grundy, S.M. (2006) Influence of body fat content and distributionon variation in metabolic risk. J. Clin. Endocrinol. Metab.,91(11), 4459-4466.
85. Zhao, D.; Grundy, S.M.; Wang, W.; Liu, J.; Zeng, Z.; Wang, W. and Wu, Z. (2007) Ten-year cardiovascular disease risk of metabolicsyndrome without central obesity in middle-aged chinese.Am. J. Cardiol., 100(5), 835-839.
86. Kraja, A.T.; Hunt, S.C.; Pankow, J.S.; Myers, R.H.; Heiss, G.; Lewis, C.E.; Rao, D. and Province, M.A. (2005) An evaluation ofthe metabolic syndrome in the HyperGEN study. Nutr. Metab.(Lond), 2(1), 2.
87. Maison, P.; Byrne, C.D.; Hales, C.N.; Day, N.E. and Wareham,N.J. (2001) Do different dimensions of the metabolic syndromechange together over time? Evidence supporting obesity as the centralfeature. Diabetes Care, 24(10), 1758-1763.
88. Meigs, J.B.; D'Agostino, R.B.Sr.; Wilson, P.W.; Cupples, L.A.; Nathan, D.M. and Singer, D.E. (1997) Risk variable clustering inthe insulin resistance syndrome. The Framingham Offspring Study.Diabetes, 4610, 1594-1600.
89. Libby, P.; Ridker, P.M. and Maseri, A. (2002) Inflammation andatherosclerosis. Circulation, 105(9), 1135-1143.
90. Nishimura, S.; Manabe, I. and Nagai, R. (2009) Adipose tissueinflammation in obesity and metabolic syndrome. Discov. Med.,8(41), 55-60.
91. Kopp, W. (2003) High-insulinogenic nutrition--an etiologic factorfor obesity and the metabolic syndrome? Metabolism, 52(7), 840-844.
92. Le Stunff, C. and Bougneres, P. (1994) Early changes in postprandialinsulin secretion, not in insulin sensitivity, characterize juvenileobesity. Diabetes, 43(5), 696-702.
93. Sigal, R.J.; El-Hashimy, M.; Martin, B.C.; Soeldner, J.S.; Krolewski, A.S. and Warram, J.H. (1997) Acute postchallenge hyperinsulinemiapredicts weight gain: a prospective study. Diabetes,46(6), 1025-1029.
94. Djousse, L.; Padilla, H.; Nelson, T.L.; Gaziano, J.M. and Mukamal,K.J. (2010) Diet and Metabolic Syndrome. Endocr. Metab. Immune.Disord. Drug Targets, 10(2), 124-139.
95. McGarry, J.D. (2002) Banting lecture 2001: dysregulation of fattyacid metabolism in the etiology of type 2 diabetes. Diabetes, 51(1),7-18.
96. Liese, A.D.; Mayer-Davis, E.J.; Tyroler, H.A.; Davis, C.E.; Keil, U.; Duncan, B.B. and Heiss, G. (1997) Development of the multiplemetabolic syndrome in the ARIC cohort: joint contribution ofinsulin, BMI, and WHR. Atherosclerosis risk in communities. Ann.Epidemiol., 7(6), 407-416.
97. Han, T.S.; Williams, K.; Sattar, N.; Hunt, K.J.; Lean, M.E. and Haffner, S.M. (2002) Analysis of obesity and hyperinsulinemia inthe development of metabolic syndrome: San Antonio Heart Study.Obes. Res., 10(9), 923-931.
98. Arnlov, J.; Ingelsson, E.; Sundstrom, J. and Lind, L. (2010) Impactof body mass index and the metabolic syndrome on the risk of cardiovasculardisease and death in middle-aged men. Circulation,121(2), 230-236.
99. Nisoli, E. and Carruba, M.O. (2004) Emerging aspects of pharmacotherapyfor obesity and metabolic syndrome. Pharmacol. Res.,50(5), 453-469.
100. Gustafson, B.; Hammarstedt, A.; Andersson, C.X. and Smith, U.(2007) Inflamed adipose tissue: a culprit underlying the metabolicsyndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol.,27(11), 2276-2283.
101. Iyer, A.; Fairlie, D.P.; Prins, J.B.; Hammock, B.D. and Brown, L.(2010) Inflammatory lipid mediators in adipocyte function andobesity. Nat. Rev. Endocrinol., 6(2), 71-82.
102. Kraja, A.T.; Province, M.A.; Arnett, D.; Wagenknecht, L.; Tang, W.; Hopkins, P.N.; Djousse, L. and Borecki, I.B. (2007) Do inflammationand procoagulation biomarkers contribute to the metabolicsyndrome cluster? Nutr. Metab. (Lond), 4, 28.
103. Mertens, I.; Verrijken, A.; Michiels, J.J.; Van der Planken, M.; Ruige, J.B. and Van Gaal, L.F. (2006) Among inflammation andcoagulation markers, PAI-1 is a true component of the metabolicsyndrome Int. J. Obes. (Lond), 30(8), 1308-1314.
104. Teran-Garcia, M. and Bouchard, C. (2007) Genetics of the metabolicsyndrome. Appl. Physiol. Nutr. Metab., 32(1), 89-114.
105. North, K.E.; Almasy, L.; Goring, H.H.; Cole, S.A.; Diego, V.P.; Laston, S.; Cantu, T.; Williams, J.T.; Howard, B.V.; Lee, E.T.; Best, L.G.; Fabsitz, R.R. and MacCluer, J.W. (2005) Linkageanalysis of factors underlying insulin resistance: Strong Heart FamilyStudy. Obes. Res., 13(11), 1877-1884.
106. Kullo, I.J.; de Andrade, M.; Boerwinkle, E.; McConnell, J.P.; Kardia, S.L. and Turner, S.T. (2005) Pleiotropic genetic effectscontribute to the correlation between HDL cholesterol, triglycerides,and LDL particle size in hypertensive sibships. Am. J. Hypertens.,18(1), 99-103.
107. Edwards, K.L.; Mahaney, M.C.; Motulsky, A.G. and Austin, M.A.(1999) Pleiotropic genetic effects on LDL size, plasma triglyceride,and HDL cholesterol in families. Arterioscler. Thromb. Vasc. Biol.,19(10), 2456-2464.
108. Kondo, H.; Shimomura, I.; Matsukawa, Y.; Kumada, M.; Takahashi, M.; Matsuda, M.; Ouchi, N.; Kihara, S.; Kawamoto, T.; Sumitsuji, S.; Funahashi, T. and Matsuzawa, Y. (2002) Association ofadiponectin mutation with type 2 diabetes: a candidate gene for theinsulin resistance syndrome. Diabetes, 51(7), 2325-2328.
109. Ohashi, K.; Ouchi, N.; Kihara, S.; Funahashi, T.; Nakamura, T.; Sumitsuji, S.; Kawamoto, T.; Matsumoto, S.; Nagaretani, H.; Kumada, M.; Okamoto, Y.; Nishizawa, H.; Kishida, K.; Maeda, N.; Hiraoka, H.; Iwashima, Y.; Ishikawa, K.; Ohishi, M.; Katsuya, T.; Rakugi, H.; Ogihara, T. and Matsuzawa, Y. (2004) AdiponectinI164T mutation is associated with the metabolic syndrome andcoronary artery disease. J. Am. Coll. Cardiol., 43(7), 1195-1200.
110. Lin, R.C.; Wang, X.L.; Dalziel, B.; Caterson, I.D. and Morris, B.J.(2003) Association of obesity, but not diabetes or hypertension,with glucocorticoid receptor N363S variant. Obes. Res., 11(6),802-808.
111. Rosmond, R. and Holm, G. (2008) A 5-year follow-up study of 3polymorphisms in the human glucocorticoid receptor gene in relationto obesity, hypertension, and diabetes. J. Cardiometab. Syndr.,3(3), 132-135.
112. Scott, L.J.; Mohlke, K.L.; Bonnycastle, L.L.; Willer, C.J.; Li, Y.; Duren, W.L.; Erdos, M.R.; Stringham, H.M.; Chines, P.S.; Jackson, A.U.; Prokunina-Olsson, L.; Ding, C.J.; Swift, A.J.; Narisu, N.; Hu, T.; Pruim, R.; Xiao, R.; Li, X.Y.; Conneely, K.N.; Riebow, N.L.; Sprau, A.G.; Tong, M.; White, P.P.; Hetrick, K.N.; Barnhart, M.W.; Bark, C.W.; Goldstein, J.L.; Watkins, L.; Xiang, F.; Saramies, J.; Buchanan, T.A.; Watanabe, R.M.; Valle, T.T.; Kinnunen, L.; Abecasis, G.R.; Pugh, E.W.; Doheny, K.F.; Bergman, R.N.; Tuomilehto, J.; Collins, F.S. and Boehnke, M.(2007) A genome-wide association study of type 2 diabetes inFinns detects multiple susceptibility variants. Science, 316(5829),1341-1345.
113. Zeggini, E.; Weedon, M.N.; Lindgren, C.M.; Frayling, T.M.; Elliott, K.S.; Lango, H.; Timpson, N.J.; Perry, J.R.; Rayner, N.W.; Freathy, R.M.; Barrett, J.C.; Shields, B.; Morris, A.P.; Ellard, S.; Groves, C.J.; Harries, L.W.; Marchini, J.L.; Owen, K.R.; Knight, B.; Cardon, L.R.; Walker, M.; Hitman, G.A.; Morris, A.D.; Doney, A.S.; McCarthy, M.I. and Hattersley, A.T. (2007) Replication ofgenome-wide association signals in UK samples reveals risk locifor type 2 diabetes. Science, 316(5829), 1336-1341.
114. Sabatti, C.; Service, S.K.; Hartikainen, A.L.; Pouta, A.; Ripatti, S.; Brodsky, J.; Jones, C.G.; Zaitlen, N.A.; Varilo, T.; Kaakinen, M.; Sovio, U.; Ruokonen, A.; Laitinen, J.; Jakkula, E.; Coin, L.; Hoggart, C.; Collins, A.; Turunen, H.; Gabriel, S.; Elliot, P.; McCarthy, M.I.; Daly, M.J.; Jarvelin, M.R.; Freimer, N.B. and Peltonen, L.(2009) Genome-wide association analysis of metabolic traits in abirth cohort from a founder population. Nat. Genet., 41(1), 35-46.
115. Aulchenko, Y.S.; Ripatti, S.; Lindqvist, I.; Boomsma, D.; Heid, I.M.; Pramstaller, P.P.; Penninx, B.W.; Janssens, A.C.; Wilson, J.F.; Spector, T.; Martin, N.G.; Pedersen, N.L.; Kyvik, K.O.; Kaprio, J.; Hofman, A.; Freimer, N.B.; Jarvelin, M.R.; Gyllensten, U.; Campbell, H.; Rudan, I.; Johansson, A.; Marroni, F.; Hayward, C.; Vitart, V.; Jonasson, I.; Pattaro, C.; Wright, A.; Hastie, N.; Pichler, I.; Hicks, A.A.; Falchi, M.; Willemsen, G.; Hottenga, J.J.; de Geus, E.J.; Montgomery, G.W.; Whitfield, J.; Magnusson, P.; Saharinen, J.; Perola, M.; Silander, K.; Isaacs, A.; Sijbrands, E.J.; Uitterlinden, A.G.; Witteman, J.C.; Oostra, B.A.; Elliott, P.; Ruokonen, A.; Sabatti, C.; Gieger, C.; Meitinger, T.; Kronenberg, F.; Doring, A.; Wichmann, H.E.; Smit, J.H.; McCarthy, M.I.; vanDuijn, C.M. and Peltonen, L. (2009) Loci influencing lipid levelsand coronary heart disease risk in 16 European population cohorts.Nat. Genet., 41(1), 47-55.
116. Kathiresan, S.; Melander, O.; Guiducci, C.; Surti, A.; Burtt, N.P.; Rieder, M.J.; Cooper, G.M.; Roos, C.; Voight, B.F.; Havulinna, A.S.; Wahlstrand, B.; Hedner, T.; Corella, D.; Tai, E.S.; Ordovas, J.M.; Berglund, G.; Vartiainen, E.; Jousilahti, P.; Hedblad, B.; Taskinen, M.R.; Newton-Cheh, C.; Salomaa, V.; Peltonen, L.; Groop, L.; Altshuler, D.M. and Orho-Melander, M. (2008) Six newloci associated with blood low-density lipoprotein cholesterol,high-density lipoprotein cholesterol or triglycerides in humans.Nat. Genet., 40(2), 189-197.
117. Willer, C.J.; Sanna, S.; Jackson, A.U.; Scuteri, A.; Bonnycastle, L.L.; Clarke, R.; Heath, S.C.; Timpson, N.J.; Najjar, S.S.; Stringham, H.M.; Strait, J.; Duren, W.L.; Maschio, A.; Busonero, F.; Mulas, A.; Albai, G.; Swift, A.J.; Morken, M.A.; Narisu, N.; Bennett, D.; Parish, S.; Shen, H.; Galan, P.; Meneton, P.; Hercberg, S.; Zelenika, D.; Chen, W.M.; Li, Y.; Scott, L.J.; Scheet, P.A.; Sundvall, J.; Watanabe, R.M.; Nagaraja, R.; Ebrahim, S.; Lawlor, D.A.; Ben-Shlomo, Y.; Davey-Smith, G.; Shuldiner, A.R.; Collins, R.; Bergman, R.N.; Uda, M.; Tuomilehto, J.; Cao, A.; Collins, F.S.; Lakatta, E.; Lathrop, G.M.; Boehnke, M.; Schlessinger, D.; Mohlke, K.L. and Abecasis, G.R. (2008)Newly identified loci thatinfluence lipid concentrations and risk of coronary artery disease.Nat. Genet., 40(2), 161-169.
118. Wallace, C.; Newhouse, S.J.; Braund, P.; Zhang, F.; Tobin, M.; Falchi, M.; Ahmadi, K.; Dobson, R.J.; Marcano, A.C.; Hajat, C.; Burton, P.; Deloukas, P.; Brown, M.; Connell, J.M.; Dominiczak, A.; Lathrop, G.M.; Webster, J.; Farrall, M.; Spector, T.; Samani, N.J.; Caulfield, M.J. and Munroe, P.B. (2008) Genome-wide associationstudy identifies genes for biomarkers of cardiovascular disease:serum urate and dyslipidemia. Am. J. Hum. Genet., 82(1),139-149.
119. Assimes, T.L.; Knowles, J.W.; Basu, A.; Iribarren, C.; Southwick,A.; Tang, H.; Absher, D.; Li, J.; Fair, J.M.; Rubin, G.D.; Sidney,S.; Fortmann, S.P.; Go, A.S.; Hlatky, M.A.; Myers, R.M.; Risch, N.and Quertermous, T. (2008) Susceptibility locus for clinical andsubclinical coronary artery disease at chromosome 9p21 in themulti-ethnic ADVANCE study. Hum. Mol. Genet., 17(15), 2320-2328.
120. Helgadottir, A.; Thorleifsson, G.; Manolescu, A.; Gretarsdottir, S.;Blondal, T.; Jonasdottir, A.; Sigurdsson, A.; Baker, A.; Palsson, A.;Masson, G.; Gudbjartsson, D.F.; Magnusson, K.P.; Andersen, K.;Levey, A.I.; Backman, V.M.; Matthiasdottir, S.; Jonsdottir, T.;Palsson, S.; Einarsdottir, H.; Gunnarsdottir, S.; Gylfason, A.; Vaccarino,V.; Hooper, W.C.; Reilly, M.P.; Granger, C.B.; Austin, H.;Rader, D.J.; Shah, S.H.; Quyyumi, A.A.; Gulcher, J.R.; Thorgeirsson,G.; Thorsteinsdottir, U.; Kong, A.; Stefansson, K. (2007) Acommon variant on chromosome 9p21 affects the risk of myocardialinfarction. Science, 316(5830), 1491-1493.
121. McCarthy, J.J. (2007) Gene by sex interaction in the etiology ofcoronary heart disease and the preceding metabolic syndrome.Nutr. Metab. Cardiovasc. Dis., 17(2), 153-161.
122. Pollex, R.L. and Hegele, R.A. (2006) Genetic determinants of themetabolic syndrome. Nat. Clin. Pract. Cardiovasc. Med., 3(9), 482-489.
123. Williams, R.R.; Rao, D.C.; Ellison, R.C.; Arnett, D.K.; Heiss, G.;Oberman, A.; Eckfeldt, J.H.; Leppert, M.F.; Province, M.A.;Mockrin, S.C. and Hunt, S.C. (2000) NHLBI family blood pressureprogram: methodology and recruitment in the HyperGEN network.Hypertension genetic epidemiology network. Ann. Epidemiol.,10(6), 389-400.
124. Province, M.A.; Arnett, D.K.; Hunt, S.C.; Leiendecker-Foster, C.;Eckfeldt, J.H.; Oberman, A.; Ellison, R.C.; Heiss, G.; Mockrin,S.C. and Williams, R.R. (2000) Association between the alphaadducingene and hypertension in the HyperGEN Study. Am. J.Hypertens., 13(6 Pt 1), 710-718.
125. Lukaski, H. Use of bioelectric impedance analysis to assess humanbody composition. In: Livingston G, Ed. Nutritional StatusAssessment of the Individual. Food and Nutrition Press, Inc., Trumball., Conn.; 1989.
126. Kraja, A.T.; Rao, D.C.; Weder, A.B.; Mosley, T.H.; Turner, S.T.;Hsiung, C.A.; Quertermous, T.; Cooper, R.; Curb, J.D. and Province,M.A. (2005) An evaluation of the metabolic syndrome in alarge multi-ethnic study: the Family Blood Pressure Program. Nutr.Metab. (Lond)., 2, 17.
127. Parikh, N.I.; Keyes, M.J.; Larson, M.G.; Pou, K.M.; Hamburg,N.M.; Vita, J.A.; O'Donnell, C.J.; Vasan, R.S.; Mitchell, G.F.;Hoffmann, U.; Fox, C.S. and Benjamin, E.J. (2009) Visceral andsubcutaneous adiposity and brachial artery vasodilator function.Obesity (Silver Spring), 17(11), 2054-2059.
128. Kannel, W. Obesity As a Force of Morbidity. In: Heald F, Ed.Adolescent Nutrition and Growth, New York: Appleton-Century-Crofts, 1969; pp. 51-71.
129. Kraja, A.T.; Huang, P.; Tang, W.; Hunt, S.C.; North, K.E.; Lewis,C.E.; Devereux, R.B.; de Simone, G.; Arnett, D.K.; Rice, T. andRao, D.C. (2008) QTLs of factors of the metabolic syndrome andechocardiographic phenotypes: the hypertension genetic epidemiologynetwork study. BMC Med. Genet., 9, 103.
130. Huang, P.; Kraja, A.T.; Tang, W.; Hunt, S.C.; North, K.E.; Lewis,C.E.; Devereux, R.B.; de Simone, G.; Arnett, D.K.; Rice, T. andRao, D.C. (2008) Factor relationships of metabolic syndrome andechocardiographic phenotypes in the HyperGEN study. J. Hypertens.,26(7), 1360-1366.
131. Huang, Z.Y.; Wu, Y.; Hedrick, N. and Gutmann, D.H. (2003) Tcadherin-mediated cell growth regulation involves G2 phase arrestand requires p21(CIP1/WAF1) expression. Mol. Cell Biol., 23(2),566-578.
132. Philippova, M.; Banfi, A.; Ivanov, D.; Gianni-Barrera, R.; Allenspach,R.; Erne, P. and Resink, T. (2006) Atypical GPIanchoredT-cadherin stimulates angiogenesis in vitro and in vivo.Arterioscler. Thromb. Vasc. Biol., 26(10), 2222-2230.
133. Kipmen-Korgun, D.; Osibow, K.; Zoratti, C.; Schraml, E.; Greilberger,J.; Kostner, G.M.; Jurgens, G. and Graier, W.F. (2005) Tcadherinmediates low-density lipoprotein-initiated cell proliferationvia the Ca(2+)-tyrosine kinase-Erk1/2 pathway. J. Cardiovasc.Pharmacol., 45(5), 418-430.
134. Org, E.; Eyheramendy, S.; Juhanson, P.; Gieger, C.; Lichtner, P.;Klopp, N.; Veldre, G.; Doring, A.; Viigimaa, M.; Sober, S.; Tomberg,K.; Eckstein, G.; Kelgo, P.; Rebane, T.; Shaw-Hawkins, S.;Howard, P.; Onipinla, A.; Dobson, R.J.; Newhouse, S.J.; Brown,M.; Dominiczak, A.; Connell, J.; Samani, N.; Farrall, M.; Caulfield,M.J.; Munroe, P.B.; Illig, T.; Wichmann, H.E.; Meitinger, T.and Laan, M. (2009) Genome-wide scan identifies CDH13 as anovel susceptibility locus contributing to blood pressure determinationin two European populations. Hum. Mol. Genet., 18(12), 2288-2296.
135. Hug, C.; Wang, J.; Ahmad, N.S.; Bogan, J.S.; Tsao, T.S. and Lodish,H.F. (2004) T-cadherin is a receptor for hexameric and highmolecular-weight forms of Acrp30/adiponectin. Proc. Natl. Acad.Sci. USA, 101(28), 10308-10313.
136. Yamauchi, T.; Kamon, J.; Ito, Y.; Tsuchida, A.; Yokomizo, T.;Kita, S.; Sugiyama, T.; Miyagishi, M.; Hara, K.; Tsunoda, M.;Murakami, K.; Ohteki, T.; Uchida, S.; Takekawa, S.; Waki, H.;rakami, K.; Ohteki, T.; Uchida, S.; Takekawa, S.; Waki, H.; Tsuno,N.H.; Shibata, Y.; Terauchi, Y.; Froguel, P.; Tobe, K.; Koyasu, S.;Taira, K.; Kitamura, T.; Shimizu, T.; Nagai, R. and Kadowaki, T.(2003) Cloning of adiponectin receptors that mediate antidiabeticmetabolic effects. Nature, 423(6941), 762-769.
137. Dolley, G.; Bertrais, S.; Frochot, V.; Bebel, J.F.; Guerre-Millo, M.;Tores, F.; Rousseau, F.; Hager, J.; Basdevant, A.; Hercberg, S.;Galan, P.; Oppert, J.M.; Lacorte, J.M. and Clement, K. (2008)Promoter adiponectin polymorphisms and waist/hip ratio variationin a prospective French adults study. Int. J. Obes. (Lond)., 32(4),669-675.
138. Guerre-Millo, M. (2008) Adiponectin: an update. Diabetes Metab.,34(1), 12-18.
139. Halvatsiotis, I.; Tsiotra, P.C.; Ikonomidis, I.; Kollias, A.; Mitrou,P.; Maratou, E.; Boutati, E.; Lekakis, J.; Dimitriadis, G.; Economopoulos,T.; Kremastinos, D.T. and Raptis, S.A. (2010) Geneticvariation in the adiponectin receptor 2 (ADIPOR2) gene is associatedwith coronary artery disease and increased ADIPOR2 expressionin peripheral monocytes. Cardiovasc. Diabetol., 9, 10.
140. Kotronen, A.; Yki-Jarvinen, H.; Aminoff, A.; Bergholm, R.; Pietilainen,K.H.; Westerbacka, J.; Talmud, P.J.; Humphries, S.E.;Hamsten, A.; Isomaa, B.; Groop, L.; Orho-Melander, M.; Ehrenborg,E. and Fisher, R.M. (2009) Genetic variation in the ADIPOR2gene is associated with liver fat content and its surrogatemarkers in three independent cohorts. Eur. J. Endocrinol., 160(4),593-602.
141. Ling, H.; Waterworth, D.M.; Stirnadel, H.A.; Pollin, T.I.; Barter,P.J.; Kesaniemi, Y.A.; Mahley, R.W.; McPherson, R.; Waeber, G.;Bersot, T.P.; Cohen, J.C.; Grundy, S.M.; Mooser, V.E. andMitchell, B.D. (2009) Genome-wide linkage and association analysesto identify genes influencing adiponectin levels: the GEMSStudy. Obesity (Silver Spring)., 17(4), 737-744.
142. Takeuchi, T.; Adachi, Y.; Ohtsuki, Y. and Furihata, M. (2007)Adiponectin receptors, with special focus on the role of the thirdreceptor, T-cadherin, in vascular disease. Med. Mol. Morphol.,40(3), 115-120.
143. Vasseur, F.; Meyre, D. and Froguel, P. (2006) Adiponectin, type 2diabetes and the metabolic syndrome: lessons from human geneticstudies. Expert Rev. Mol. Med., 8(27), 1-12.
144. Vaxillaire, M.; Dechaume, A.; Vasseur-Delannoy, V.; Lahmidi, S.;Vatin, V.; Lepretre, F.; Boutin, P.; Hercberg, S.; Charpentier, G.;Dina, C. and Froguel, P. (2006) Genetic analysis of ADIPOR1 andADIPOR2 candidate polymorphisms for type 2 diabetes in theCaucasian population. Diabetes, 55(3), 856-861.
145. Hebbard, L.W.; Garlatti, M.; Young, L.J.; Cardiff, R.D.; Oshima,R.G. and Ranscht, B. (2008) T-cadherin supports angiogenesis andadiponectin association with the vasculature in a mouse mammarytumor model. Cancer Res., 68(5), 1407-1416.
146. Kadowaki, T.; Yamauchi, T.; Kubota, N.; Hara, K.; Ueki, K. andTobe, K. (2006) Adiponectin and adiponectin receptors in insulinresistance, diabetes, and the metabolic syndrome. J. Clin. Invest.,116(7), 1784-1792.
147. Nishida, M.; Funahashi, T. and Shimomura, I. (2007) Pathophysiologicalsignificance of adiponectin. Med. Mol. Morphol., 40(2),55-67.
148. Philippova, M.; Joshi, M.B.; Kyriakakis, E.; Pfaff, D.; Erne, P. andResink, T.J. (2009) A guide and guard: the many faces of Tcadherin.Cell Signal, 21(7), 1035-1044.
149. Joy, T.; Lahiry, P.; Pollex, R.L. and Hegele, R.A. (2008) Geneticsof metabolic syndrome. Curr. Diab. Rep., 8(2), 141-148.
150. Lawson, H.A. and Cheverud, J.M. (2010) Metabolic syndromecomponents in murine models. Endocr. Metab. Immune. Disord.Drug Targets, 10(1), 25-40.
151. Su, Z.; Korstanje, R.; Tsaih, S.W. and Paigen, B. (2008) Candidategenes for obesity revealed from a C57BL/6J x 129S1/SvImJ intercross.Int. J. Obes. (Lond), 32(7), 1180-1189.
152. Hinney, A. and Hebebrand, J. (2008) Polygenic obesity in humans.Obes. Facts, 1(1), 35-42.
153. Hinney, A.; Vogel, C.I. and Hebebrand J. (2010) From monogenicto polygenic obesity: recent advances. Eur. Child Adolesc. Psychiatry,19(3), 297-310.
154. Tonjes, A.; Zeggini, E.; Kovacs, P.; Bottcher, Y.; Schleinitz, D.;Dietrich, K.; Morris, A.P.; Enigk, B.; Rayner, N.W.; Koriath, M.;Eszlinger, M.; Kemppinen, A.; Prokopenko, I.; Hoffmann, K.; Teupser,D.; Thiery, J.; Krohn, K.; McCarthy, M.I. and Stumvoll, M.(2010) Association of FTO variants with BMI and fat mass in theself-contained population of Sorbs in Germany. Eur. J. Hum.Genet., 18(1), 104-110.
155. Johansson, A.; Marroni, F.; Hayward, C.; Franklin, C.S.;Kirichenko, A.V.; Jonasson, I.; Hicks, A.A.; Vitart, V.; Isaacs, A.;Axenovich, T.; Campbell, S.; Floyd, J.; Hastie, N.; Knott, S.; Lauc,G.; Pichler, I.; Rotim, K.; Wild, S.H.; Zorkoltseva, I.V.; Wilson,J.F.; Rudan, I.; Campbell, H.; Pattaro, C.; Pramstaller, P.; Oostra,B.A.; Wright, A.F.; van Duijn, C.M.; Aulchenko, Y.S. and GyllenstenU. (2010) Linkage and genome-wide association analysis ofobesity-related phenotypes: association of weight with the MGAT1gene. Obesity (Silver Spring), 18(4), 803-808.
156. Fox, C.S.; Heard-Costa, N.; Cupples, L.A.; Dupuis, J.; Vasan, R.S.and Atwood, L.D. (2007) Genome-wide association to body massindex and waist circumference: the Framingham Heart Study 100Kproject. BMC Med. Genet., 8(Suppl 1), S18.
157. Cho, Y.S.; Go, M.J.; Kim, Y.J.; Heo, J.Y.; Oh, J.H.; Ban, H.J.;Yoon, D.; Lee, M.H.; Kim, D.J.; Park, M.; Cha, S.H.; Kim, J.W.;Han, B.G.; Min, H.; Ahn, Y.; Park, M.S.; Han, H.R.; Jang, H.Y.;Cho, E.Y.; Lee, J.E.; Cho, N.H.; Shin, C.; Park, T.; Park, J.W.; Lee,J.K.; Cardon, L.; Clarke, G.; McCarthy, M.I.; Lee, J.Y.; Lee, J.K.;Oh, B. and Kim, H.L. (2009) A large-scale genome-wide associationstudy of Asian populations uncovers genetic factors influencingeight quantitative traits. Nat. Genet., 41(5), 527-534.
158. Wang, Y.; O'Connell, J.R.; McArdle, P.F.; Wade, J.B.; Dorff, S.E.;Shah, S.J.; Shi, X.; Pan, L.; Rampersaud, E.; Shen, H.; Kim, J.D.;Subramanya, A.R.; Steinle, N.I.; Parsa, A.; Ober, C.C.; Welling,P.A.; Chakravarti, A.; Weder, A.B.; Cooper, R.S.; Mitchell, B.D.;Shuldiner, A.R. and Chang, Y.P. (2009) From the Cover: Wholegenomeassociation study identifies STK39 as a hypertension susceptibilitygene. Proc. Natl. Acad. Sci. USA, 106(1), 226-231.
159. Levy, D.; Ehret, G.B.; Rice, K.; Verwoert, G.C.; Launer, L.J.; Dehghan, A.; Glazer, N.L.; Morrison, A.C.; Johnson, A.D.; Aspelund, T.; Aulchenko, Y.; Lumley, T.; Kottgen, A.; Vasan, R.S.; Rivadeneira, F.; Eiriksdottir, G.; Guo, X.; Arking, D.E.; Mitchell, G.F.; Mattace-Raso, F.U.; Smith, A.V.; Taylor, K.; Scharpf, R.B.; Hwang, S.J.; Sijbrands, E.J.; Bis, J.; Harris, T.B.; Ganesh, S.K.; O'Donnell, C.J.; Hofman, A.; Rotter, J.I.; Coresh, J.; Benjamin, E.J.; Uitterlinden, A.G.; Heiss, G.; Fox, C.S.; Witteman, J.C.; Boerwinkle, E.; Wang, T.J.; Gudnason, V.; Larson, M.G.; Chakravarti, A.; Psaty, B.M. and van Duijn, C.M. (2009) Genome-wideassociation study of blood pressure and hypertension. Nat. Genet.,[Epub ahead of print].
160. Newton-Cheh, C.; Johnson, T.; Gateva, V.; Tobin, M.D.; Bochud, M.; Coin, L.; Najjar, S.S.; Zhao, J.H.; Heath, S.C.; Eyheramendy, S.; Papadakis, K.; Voight, B.F.; Scott, L.J.; Zhang, F.; Farrall, M.; Tanaka, T.; Wallace, C.; Chambers, J.C.; Khaw, K.T.; Nilsson, P.; van der Harst, P.; Polidoro, S.; Grobbee, DE.; Onland-Moret, N.C.; Bots, M.L.; Wain, L.V.; Elliott, K.S.; Teumer, A.; Luan, J.; Lucas, G.; Kuusisto, J.; Burton, P.R.; Hadley, D.; McArdle, W.L.; Brown, M.; Dominiczak, A.; Newhouse, S.J.; Samani, N.J.; Webster, J.; Zeggini, E.; Beckmann, J.S.; Bergmann, S.; Lim, N.; Song, K.; Vollenweider, P.; Waeber, G.; Waterworth, D.M.; Yuan, X.; Groop, L.; Orho-Melander, M.; Allione, A.; Di Gregorio, A.; Guarrera, S.; Panico, S.; Ricceri, F.; Romanazzi, V.; Sacerdote, C.; Vineis, P.; Barroso, I.; Sandhu, M.S.; Luben, R.N.; Crawford, G.J.; Jousilahti, P.; Perola, M.; Boehnke, M.; Bonnycastle, L.L.; Collins, F.S.; Jackson, A.U.; Mohlke, K.L.; Stringham, H.M.; Valle, T.T.; Willer, C.J.; Bergman, R.N.; Morken, M.A.; Doring, A.; Gieger, C.; Illig, T.; Meitinger, T.; Org, E.; Pfeufer, A.; Wichmann, H.E.; Kathiresan, S.; Marrugat, J.; O'Donnell, C.J.; Schwartz, S.M.; Siscovick, D.S.; Subirana, I.; Freimer, N.B.; Hartikainen, A.L.; McCarthy, M.I.; O'Reilly, P.F.; Peltonen, L.; Pouta, A.; de Jong, P.E.; Snieder, H.; van Gilst, W.H.; Clarke, R.; Goel, A.; Hamsten, A.x et-al(2009) Genome-wide association study identifieseight loci associated with blood pressure. Nat. Genet., [Epub aheadof print].
161. Kooner, J.S.; Chambers, J.C.; Aguilar-Salinas, C.A.; Hinds, D.A.; Hyde, C.L.; Warnes, G.R.; Gomez Perez, F.J.; Frazer, K.A.; Elliott, P.; Scott, J.; Milos, P.M.; Cox, D.R. and Thompson, J.F. (2008)Genome-wide scan identifies variation in MLXIPL associated withplasma triglycerides. Nat. Genet., 40(2), 149-151.
162. Hiura, Y.; Shen, C.S.; Kokubo, Y.; Okamura, T.; Morisaki, T.;Tomoike, H.; Yoshida, T.; Sakamoto, H.; Goto, Y.; Nonogi, H. andIwai, N. (2009) Identification of genetic markers associated withhigh-density lipoprotein-cholesterol by genome-wide screening in aJapanese population: the Suita study. Circ. J., 73(6), 1119-1126.
163. Burkhardt, R.; Kenny, E.E.; Lowe, J.K.; Birkeland, A.; Josowitz,R.; Noel, M.; Salit, J.; Maller, J.B.; Pe'er, I.; Daly, M.J.; Altshuler,D.; Stoffel, M.; Friedman, J.M. and Breslow, J.L. (2008) CommonSNPs in HMGCR in micronesians and whites associated withLDL-cholesterol levels affect alternative splicing of exon13.Arterioscler. Thromb. Vasc. Biol., 28(11), 2078-2084.
164. Pollin, T.I.; Damcott, C.M.; Shen, H.; Ott, S.H.; Shelton, J.; Horenstein,R.B.; Post, W.; McLenithan, J.C.; Bielak, L.F.; Peyser, P.A.;Mitchell, B.D.; Miller, M.; O'Connell, J.R. and Shuldiner, A.R.(2008) A null mutation in human APOC3 confers a favorableplasma lipid profile and apparent cardioprotection. Science,322(5908), 1702-1705.
165. Sandhu, M.S.; Waterworth, D.M.; Debenham, S.L.; Wheeler, E.;Papadakis, K.; Zhao, J.H.; Song, K.; Yuan, X.; Johnson, T.; Ashford,S.; Inouye, M.; Luben, R.; Sims, M.; Hadley, D.; McArdle,W.; Barter, P.; Kesaniemi, Y.A.; Mahley, R.W.; McPherson, R.;Grundy, S.M.; Bingham, S.A.; Khaw, K.T.; Loos, R.J.; Waeber,G.; Barroso, I.; Strachan, D.P.; Deloukas, P.; Vollenweider, P.;Wareham, N.J. and Mooser, V. (2008) LDL-cholesterol concentrations:a genome-wide association study. Lancet, 371(9611) 483-491.
166. Zemunik, T.; Boban, M.; Lauc, G.; Jankovic, S.; Rotim, K.; Vatavuk,Z.; Bencic, G.; Dogas, Z.; Boraska, V.; Torlak, V.; Susac, J.;Zobic, I.; Rudan, D.; Pulanic, D.; Modun, D.; Mudnic, I.; Gunjaca,G.; Budimir, D.; Hayward, C.; Vitart, V.; Wright, A.F.; Campbell,H. and Rudan, I. (2009) Genome-wide association study of biochemicaltraits in Korcula Island.; Croatia. Croat. Med. J., 50(1),23-33.
167. Heid, I.M.; Henneman, P.; Hicks, A.; Coassin, S.; Winkler, T.; Aulchenko, Y.S.; Fuchsberger, C.; Song, K.; Hivert, M.F.; Waterworth, D.M.; Timpson, N.J.; Richards, J.B.; Perry, J.R.; Tanaka, T.; Amin, N.; Kollerits, B.; Pichler, I.; Oostra, B.A.; Thorand, B.;Frants, R.R.; Illig, T.; Dupuis, J.; Glaser, B.; Spector T.; Guralnik,J.; Egan, J.M.; Florez, J.C.; Evans, D.M.; Soranzo, N.; Bandinelli,S.; Carlson, O.D.; Frayling, T.M.; Burling, K.; Smith, G.D.;Mooser, V.; Ferrucci, L.; Meigs, J.B.; Vollenweider, P.; Dijk,K.W.; Pramstaller, P.; Kronenberg, F. and van Duijn, C.M. (2010)Clear detection of ADIPOQ locus as the major gene for plasmaadiponectin: results of genome-wide association analyses including4659 European individuals. Atherosclerosis, 208(2), 412-420.
168. Richards, J.B.; Waterworth, D.; O'Rahilly, S.; Hivert, M.F.; Loos, R.J.; Perry, J.R.; Tanaka, T.; Timpson, N.J.; Semple, R.K.; Soranzo, N.; Song, K.; Rocha, N.; Grundberg, E.; Dupuis, J.; Florez, J.C.; Langenberg, C.; Prokopenko, I.; Saxena, R.; Sladek, R.; Aulchenko, Y.; Evans, D.; Waeber, G.; Erdmann, J.; Burnett, M.S.; Sattar, N.; Devaney, J.; Willenborg, C.; Hingorani, A.; Witteman, J.C.; Vollenweider, P.; Glaser, B.; Hengstenberg, C.; Ferrucci, L.; Melzer, D.; Stark, K.; Deanfield, J.; Winogradow, J.; Grassl, M.; Hall, A.S.; Egan, J.M.; Thompson, J.R.; Ricketts, S.L.; Konig, I.R.; Reinhard, W.; Grundy, S.; Wichmann, H.E.; Barter, P.; Mahley, R.; Kesaniemi, Y.A.; Rader, D.J.; Reilly, M.P.; Epstein, S.E.; Stewart, A.F.; Van Duijn, C.M.; Schunkert, H.; Burling, K.; Deloukas, P.; Pastinen, T.; Samani, N.J.; McPherson, R.; DaveySmith, G.; Frayling, T.M.; Wareham, N.J.; Meigs, J.B.; Mooser, V. and Spector, T.D. (2009) A genome-wide association study revealsvariants in ARL15 that influence adiponectin levels. PLoS Genet.,5(12), e1000768.
169. Danik, J.S.; Pare, G.; Chasman, D.I.; Zee, R.Y.; Kwiatkowski, D.J.;Parker, A.; Miletich, J.P. and Ridker, P.M. (2009) Novel loci: includingthose related to Crohn disease: psoriasis: and inflammation:identified in a genome-wide association study of fibrinogen in 17686 women: the Women's Genome Health Study. Circ. Cardiovasc.Genet., 2(2), 134-41.
170. Dehghan, A.; Yang, Q.; Peters, A.; Basu, S.; Bis, J.C.; Rudnicka,A.R.; Kavousi, M.; Chen, M.H.; Baumert, J.; Lowe, G.D.;McKnight, B.; Tang, W.; de Maat, M.; Larson, M.G.; Eyhermendy,S.; McArdle, WL.; Lumley, T.; Pankow, J.S.; Hofman, A.; Massaro,J.M.; Rivadeneira, F.; Kolz, M.; Taylor, K.D.; van Duijn,C.M.; Kathiresan, S.; Illig, T.; Aulchenko, Y.S.; Volcik, K.A.;Johnson, A.D.; Uitterlinden, A.G.; Tofler, G.H.; Gieger, C.; Psaty,B.M.; Couper, D.J.; Boerwinkle, E.; Koenig, W.; O'Donnell, C.J.;Witteman, J.C.; Strachan, D.P.; Smith, N.L. and Folsom, A.R.(2009) Association of novel genetic Loci with circulating fibrinogenlevels: a genome-wide association study in 6 population-basedcohorts. Circ. Cardiovasc. Genet., 2(2), 125-133.
171. Elliott, P.; Chambers, J.C.; Zhang, W.; Clarke, R.; Hopewell, J.C.;Peden, J.F.; Erdmann, J.; Braund, P.; Engert, J.C.; Bennett, D.;Coin, L.; Ashby, D.; Tzoulaki, I.; Brown, I.J.; Mt-Isa, S.;McCarthy, M.I.; Peltonen, L.; Freimer, N.B.; Farrall, M.; Ruokonen,A.; Hamsten, A.; Lim, N.; Froguel, P.; Waterworth, D.M.;Vollenweider, P.; Waeber, G.; Jarvelin, M.R.; Mooser, V.; Scott, J.;Hall, A.S.; Schunkert, H.; Anand, S.S.; Collins, R.; Samani, N.J.;Watkins, H. and Kooner, J.S. (2009) Genetic Loci associated withC-reactive protein levels and risk of coronary heart disease. JAMA,302(1), 37-48.
172. Reiner, A.P.; Barber, M.J.; Guan, Y.; Ridker, P.M.; Lange, L.A.;Chasman, D.I.; Walston, J.D.; Cooper, G.M.; Jenny, N.S.; Rieder,M.J.; Durda, J.P.; Smith, J.D.; Novembre, J.; Tracy, R.P.; Rotter,J.I.; Stephens, M.; Nickerson, D.A. and Krauss, R.M. (2008) Polymorphismsof the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am. J. Hum.Genet., 82(5), 1193-1201.
173. Chen, W.M.; Erdos, M.R.; Jackson, A.U.; Saxena, R.; Sanna, S.; Silver, K.D.; Timpson, N.J.; Hansen, T.; Orru, M.; Grazia Piras, M.; Bonnycastle, L.L.; Willer, C.J.; Lyssenko, V.; Shen, H.;Kuusisto, J.; Ebrahim, S.; Sestu, N.; Duren, W.L.; Spada, M.C.;Stringham, H.M.; Scott, L.J.; Olla, N.; Swift, A.J.; Najjar, S.;Mitchell, B.D.; Lawlor, D.A.; Smith, G.D.; Ben-Shlomo, Y.; Andersen,G.; Borch-Johnsen, K.; Jorgensen, T.; Saramies, J.; Valle,T.T.; Buchanan, T.A.; Shuldiner, A.R.; Lakatta, E.; Bergman, R.N.;Uda, M.; Tuomilehto, J.; Pedersen, O.; Cao, A.; Groop, L.;Mohlke, K.L.; Laakso, M.; Schlessinger, D.; Collins, F.S.; Altshuler,D.; Abecasis, G.R.; Boehnke, M.; Scuteri, A. and Watanabe,RM. (2008) Variations in the G6PC2/ABCB11 genomic regionare associated with fasting glucose levels. J. Clin. Invest.,118(7), 2620-2628.
174. Bouatia-Naji, N.; Bonnefond, A.; Cavalcanti-Proenca, C.; Sparso,T.; Holmkvist, J.; Marchand, M.; Delplanque, J.; Lobbens, S.;Rocheleau, G.; Durand, E.; De Graeve, F.; Chevre, J.C.; Borch-Johnsen, K.; Hartikainen, A.L.; Ruokonen, A.; Tichet, J.; Marre,M.; Weill, J.; Heude, B.; Tauber, M.; Lemaire, K.; Schuit, F.; Elliott, P.; Jorgensen, T.; Charpentier, G.; Hadjadj, S.; Cauchi, S.;Vaxillaire, M.; Sladek, R.; Visvikis-Siest, S.; Balkau, B.; Levy-Marchal, C.; Pattou, F.; Meyre, D.; Blakemore, A.I.; Jarvelin,M.R.; Walley, A.J.; Hansen, T.; Dina, C.; Pedersen, O. and FroguelP. (2009) A variant near MTNR1B is associated with increasedfasting plasma glucose levels and type 2 diabetes risk. Nat. Genet.,41(1), 89-94.
175. Chambers, J.C.; Zhang, W.; Zabaneh, D.; Sehmi, J.; Jain, P.;McCarthy, M.I.; Froguel, P.; Ruokonen, A.; Balding, D.; Jarvelin,M.R.; Scott, J.; Elliott, P. and Kooner, J.S. (2009) Common geneticvariation near melatonin receptor MTNR1B contributes to raisedplasma glucose and increased risk of type 2 diabetes among IndianAsians and European Caucasians. Diabetes, 58(11), 2703-2708.
176. Takeuchi, F.; Serizawa, M.; Yamamoto, K.; Fujisawa, T.; Nakashima,E.; Ohnaka, K.; Ikegami, H.; Sugiyama, T.; Katsuya, T.;Miyagishi, M.; Nakashima, N.; Nawata, H.; Nakamura, J.; Kono,S.; Takayanagi, R. and Kato N. (2009) Confirmation of multiplerisk Loci and genetic impacts by a genome-wide association studyof type 2 diabetes in the Japanese population. Diabetes, 58(7),1690-1699.
177. Steinthorsdottir, V.; Thorleifsson, G.; Reynisdottir, I.;Benediktsson, R.; Jonsdottir, T.; Walters, G.B.; Styrkarsdottir, U.;Gretarsdottir, S.; Emilsson, V.; Ghosh, S.; Baker, A.; Snorradottir,S.; Bjarnason, H.; Ng, M.C.; Hansen, T.; Bagger, Y.; Wilensky,R.L.; Reilly, M.P.; Adeyemo, A.; Chen, Y.; Zhou, J.; Gudnason,V.; Chen, G.; Huang, H.; Lashley, K.; Doumatey, A.; So, W.Y.;Ma, R.C.; Andersen, G.; Borch-Johnsen, K.; Jorgensen, T.; vanVliet-Ostaptchouk, J.V.; Hofker, M.H.; Wijmenga, C.; Christiansen,C.; Rader, D.J.; Rotimi, C.; Gurney, M.; Chan, J.C.; Pedersen, O.;Sigurdsson, G.; Gulcher, J.R.; Thorsteinsdottir, U.; Kong, A. andStefansson, K. (2007) A variant in CDKAL1 influences insulinresponse and risk of type 2 diabetes. Nat. Genet., 39(6), 770-775.
178. Sladek, R.; Rocheleau, G.; Rung, J.; Dina, C.; Shen, L.; Serre, D.;Boutin, P.; Vincent, D.; Belisle, A.; Hadjadj, S.; Balkau, B.; Heude,B.; Charpentier, G.; Hudson, T.J.; Montpetit, A.; Pshezhetsky,A.V.; Prentki, M.; Posner, B.I.; Balding, D.J.; Meyre, D.; Polychronakos,C. and Froguel, P. (2007) A genome-wide associationstudy identifies novel risk loci for type 2 diabetes. Nature,445(7130), 881-885.
179. Yasuda, K.; Miyake, K.; Horikawa, Y.; Hara, K.; Osawa, H.; Furuta,H.; Hirota, Y.; Mori, H.; Jonsson, A.; Sato, Y.; Yamagata, K.;Hinokio, Y.; Wang, H.Y.; Tanahashi, T.; Nakamura, N.; Oka, Y.;Iwasaki, N.; Iwamoto, Y.; Yamada, Y.; Seino, Y.; Maegawa, H.;Kashiwagi, A.; Takeda, J.; Maeda, E.; Shin, H.D.; Cho, Y.M.;Park, K.S.; Lee, H.K.; Ng, M.C.; Ma, R.C.; So, W.Y.; Chan, J.C.;Lyssenko, V.; Tuomi, T.; Nilsson, P.; Groop, L.; Kamatani, N.; Sekine,A.; Nakamura, Y.; Yamamoto, K.; Yoshida, T.; Tokunaga,K.; Itakura, M.; Makino, H.; Nanjo, K.; Kadowaki, T. and Kasuga,M. (2008) Variants in KCNQ1 are associated with susceptibility totype 2 diabetes mellitus. Nat. Genet., 40(9), 1092-1097.
180. noki, H.; Takahashi, A.; Kawaguchi, T.; H/xnamexara/x/namex, K.; Horikoshi, M.;Andersen, G.; Ng, D.P.; Holmkvist, J.; Borch-Johnsen, K.; Jorgensen,T.; Sandbaek, A.; Lauritzen, T.; Hansen, T.; Nurbaya, S.;Tsunoda, T.; Kubo, M.; Babazono, T.; Hirose, H.; Hayashi, M.;Iwamoto, Y.; Kashiwagi, A.; Kaku, K.; Kawamori, R.; Tai, E.S.;Pedersen, O.; Kamatani, N.; Kadowaki, T.; Kikkawa, R.; Nakamura,Y. and Maeda, S. (2008) SNPs in KCNQ1 are associatedwith susceptibility to type 2 diabetes in East Asian and Europeanpopulations. Nat. Genet., 40(9), 1098-1102.
181. Meigs, J.B.; Manning, A.K.; Fox, C.S.; Florez, J.C.; Liu, C.; Cupples,L.A. and Dupuis J. (2007) Genome-wide association withdiabetes-related traits in the Framingham Heart Study. BMC Med.Genet., 8(Suppl 1), S16.
182. Tsai, F.J.; Yang, C.F.; Chen, C.C.; Chuang, L.M.; Lu, C.H.; Chang,C.T.; Wang, T.Y.; Chen, R.H.; Shiu, C.F.; Liu, Y.M.; Chang, C.C.;Chen, P.; Chen, C.H.; Fann, C.S.; Chen, Y.T. and Wu, J.Y. (2010)A genome-wide association study identifies susceptibility variantsfor type 2 diabetes in Han Chinese. PLoS Genet., 6(2), e1000847.
183. Wellcome Trust Case Control Consortium. (2007) Genome-wideassociation study of 14,000 cases of seven common diseases and3,000 shared controls. Nature, 447(7145), 661-678.
184. Salonen, J.T.; Uimari, P.; Aalto, J.M.; Pirskanen, M.; Kaikkonen,J.; Todorova, B.; Hypponen, J.; Korhonen, V.P.; Asikainen, J.;Devine, C.; Tuomainen, T.P.; Luedemann, J.; Nauck, M.; Kerner,W.; Stephens, R.H.; New, J.P.; Ollier, W.E.; Gibson, J.M.; Payton,A.; Horan, M.A.; Pendleton, N.; Mahoney, W.; Meyre, D.;Delplanque, J.; Froguel, P.; Luzzatto, O.; Yakir, B. and Darvasi, A.(2007) Type 2 diabetes whole-genome association study in fourpopulations: the DiaGen consortium. Am. J. Hum. Genet., 81(2),338-345.
185. Timpson, N.J.; Lindgren, C.M.; Weedon, M.N.; Randall, J.; Ouwehand,W.H.; Strachan, D.P.; Rayner, N.W.; Walker, M.; Hitman,G.A.; Doney, A.S.; Palmer, C.N.; Morris, A.D.; Hattersley, A.T.;Zeggini, E.; Frayling, T.M. and McCarthy, M.I. (2009) Adiposityrelatedheterogeneity in patterns of type 2 diabetes susceptibilityobserved in genome-wide association data. Diabetes, 58(2), 505-510.
186. Prokopenko, I.; Langenberg, C.; Florez, J.C.; Saxena, R.; Soranzo, N.; Thorleifsson, G.; Loos, R.J.; Manning, A.K.; Jackson, A.U.; Aulchenko, Y.; Potter, S.C.; Erdos, M.R.; Sanna, S.; Hottenga, J.J.; Wheeler, E.; Kaakinen, M.; Lyssenko, V.; Chen, W.M.; Ahmadi, K.; Beckmann, J.S.; Bergman, R.N.; Bochud, M.; Bonnycastle, L.L.; Buchanan, T.A.; Cao, A.; Cervino, A.; Coin, L.; Collins, F.S.; Crisponi, L.; de Geus, E.J.; Dehghan, A.; Deloukas, P.; Doney, A.S.; Elliott, P.; Freimer, N.; Gateva, V.; Herder, C.; Hofman, A.; Hughes, T.E.; Hunt, S.; Illig, T.; Inouye, M.; Isomaa, B.; Johnson, T.; Kong, A.; Krestyaninova, M.; Kuusisto, J.; Laakso, M.; Lim, N.; Lindblad, U.; Lindgren, C.M.; McCann, O.T.; Mohlke, K.L.; Morris, A.D.; Naitza, S.; Orru, M.; Palmer, C.N.; Pouta, A.; Randall, J.; Rathmann, W.; Saramies, J.; Scheet, P.; Scott, L.J.; Scuteri, A.; Sharp, S.; Sijbrands, E.; Smit, J.H.; Song, K.; Steinthorsdottir, V.; Stringham, H.M.; Tuomi, T.; Tuomilehto, J.; Uitterlinden, A.G.; Voight, B.F.; Waterworth, D.; Wichmann, H.E.; Willemsen, G.; Witteman, J.C.; Yuan, X.; Zhao, J.H.; Zeggini, E.; Schlessinger, D.; Sandhu, M.; Boomsma, D.I.; Uda, M.; Spector, T.D.; Penninx, B.W.; Altshuler, D.; Vollenweider, P.; Jarvelin, M.R.; Lakatta, E.; Waeber, G.; Fox, C.S.; Peltonen, L.; Groop, L.C.; Mooser, V.; Cupples, LA.; Thorsteinsdottir, U.; Boehnke, M.; Barroso, I.; Van Duijn, C.; Dupuis, J.; Watanabe, R.M.; et al. (2009) Variants in MTNR1B influence fasting glucose levels.Nat. Genet., 41(1), 77-81.
187. Saxena, R.; Voight, B.F.; Lyssenko, V.; Burtt, N.P.; de Bakker, P.I.; Chen, H.; Roix, J.J.; Kathiresan, S.; Hirschhorn, J.N.; Daly, M.J.; Hughes, T.E.; Groop, L.; Altshuler, D.; Almgren, P.; Florez, J.C.; Meyer, J.; Ardlie, K.; Bengtsson Bostrom, K.; Isomaa, B.; Lettre, G.; Lindblad, U.; Lyon, H.N.; Melander, O.; Newton-Cheh, C.; Nilsson, P.; Orho-Melander, M.; Rastam, L.; Speliotes, E.K.; Taskinen, M.R.; Tuomi, T.; Guiducci, C.; Berglund, A.; Carlson, J.; Gianniny, L.; Hackett, R.; Hall, L.; Holmkvist, J.; Laurila, E.; Sjogren, M.; Sterner, M.; Surti, A.; Svensson, M.; Tewhey, R.; Blumenstiel, B.; Parkin, M.; Defelice, M.; Barry, R.; Brodeur, W.; Camarata, J.; Chia, N.; Fava, M.; Gibbons, J.; Handsaker, B.; Healy, C.; Nguyen, K.; Gates, C.; Sougnez, C.; Gage, D.; Nizzari, M.; Gabriel, S.B.; Chirn, G.W.; Ma, Q.; Parikh, H.; Richardson, D.; Ricke, D. and Purcell S. (2007) Genome-wide association analysisidentifies loci for type 2 diabetes and triglyceride levels. Science,316(5829), 1331-1336.
188. Hanson, R.L.; Bogardus, C.; Duggan, D.; Kobes, S.; Knowlton, M.;Infante, A.M.; Marovich, L.; Benitez, D.; Baier, L.J. and Knowler,W.C. (2007) A search for variants associated with young-onsettype 2 diabetes in American Indians in a 100K genotyping array.Diabetes, 56(12), 3045-3052.
189. Hayes, M.G.; Pluzhnikov, A.; Miyake, K.; Sun, Y.; Ng, M.C.; Roe,C.A.; Below, J.E.; Nicolae, R.I.; Konkashbaev, A.; Bell, G.I.; Cox,N.J. and Hanis, C.L. (2007) Identification of type 2 diabetes genesin Mexican Americans through genome-wide association studies.Diabetes, 56(12), 3033-3044.
190. Rampersaud, E.; Damcott, C.M.; Fu, M.; Shen, H.; McArdle, P.;Shi, X.; Shelton, J.; Yin, J.; Chang, Y.P.; Ott, S.H.; Zhang, L.;Zhao, Y.; Mitchell, B.D.; O'Connell, J. and Shuldiner, A.R. (2007)Identification of novel candidate genes for type 2 diabetes from agenome-wide association scan in the Old Order Amish: evidencefor replication from diabetes-related quantitative traits and from independentpopulations. Diabetes, 56(12), 3053-3062.
191. Hindorff, L.A.; Junkins, H.A.; Mehta, J.P. and Manolio, T.A.(2010) A catalog of published genome-wide associaiton studies.
192. Manolio, T.A.; Collins, F.S.; Cox, N.J.; Goldstein, D.B.; Hindorff,L.A.; Hunter, D.J.; McCarthy, M.I.; Ramos, E.M.; Cardon, L.R.;Chakravarti, A.; Cho, J.H.; Guttmacher, A.E.; Kong, A.; Kruglyak,L.; Mardis, E.; Rotimi, C.N.; Slatkin, M.; Valle, D.; Whittemore,A.S.; Boehnke, M.; Clark, A.G.; Eichler, E.E.; Gibson, G.; Haines,J.L.; Mackay, T.F.; McCarroll, S.A. and Visscher, P.M. (2009)Finding the missing heritability of complex diseases. Nature,461(7265), 747-753.
193. Hindorff, L.A.; Sethupathy, P.; Junkins, H.A.; Ramos, E.M.; Mehta,J.P.; Collins, F.S. and Manolio, T.A. (2009) Potential etiologicand functional implications of genome-wide association loci forhuman diseases and traits. Proc. Natl. Acad. Sci. USA, 106(23),9362-9367.
194. Kraja, A.T.; Vaidya, D.; Pankow, J.S.; Goodarzi, M.O.; Assimes,T.L.; Kullo, I.; Sovio, U.; Mathias, R.A.; Sun, Y.V.; Franceschini,N.; Absher, D.; Li, G.; Zhang, Q.; Feitosa, M.F.; Glazer, N.L.;Haritunians, T.; Hartikainen, A.L.; Knowles, J.W.; North, K.E.;Iribarren, C.; Kral, B.; Yanek, L.; O'Reilly, P.; McCarthy, M.;Jaquish, C.; Couper, D.J.; Chakravarti, A.; Psaty, B.M.; Becker,L.C.; Province, M.A.; Boerwinkle, E.; Quertermous, T.; Peltonen,L.; Jarvelin, M.R.; Becker, D.M.; Kardia, S.L.R.; Rotter, J.I.; Chen,Y.I.; Borecki, I.B. (submitted) A bivariate genome-wide approachto metabolic syndrome: STAMPEED Consortium. Annals of InternalMedicine.
195. Mardis, E.R. (2009) New strategies and emerging technologies formassively parallel sequencing: applications in medical research.Genome Med., 1(4), 40.
196. Andriole, K.P. and Khorasani, R. (2010) Cloud computing: what isit and could it be useful? J. Am. Coll. Radiol., 7(4), 252-254.
197. Joy, T. and Hegele, R.A. (2008) Genetics of metabolic syndrome:is there a role for phenomics? Curr. Atheroscler. Rep., 10(3), 201-208.
198. Lynn, F.C. (2009) Meta-regulation: microRNA regulation of glucoseand lipid metabolism. Trends Endocrinol. Metab., 20(9), 452-459.
199. Kim, M.; Long, T.I.; Arakawa, K.; Wang, R.; Yu, M.C. and Laird,P.W. (2010) DNA methylation as a biomarker for cardiovasculardisease risk. PLoS One, 5(3), e9692.
200. Heid, I.M.; Boes, E.; Muller, M.; Kollerits, B.; Lamina, C.;Coassin, S.; Gieger, C.; Doring, A.; Klopp, N.; Frikke-Schmidt, R.;Tybjaerg-Hansen, A.; Brandstatter, A.; Luchner, A.; Meitinger, T.;Wichmann, H.E. and Kronenberg, F. (2008) Genome-wide associationanalysis of high-density lipoprotein cholesterol in the population-based KORA study sheds new light on intergenic regions.Circ. Cardiovasc. Genet., 1(1), 10-20.
201. Ridker, P.M.; Pare, G.; Parker, A.N.; Zee, R.Y.; Miletich, J.P. andChasman, D.I. (2009) Polymorphism in the CETP gene region,HDL cholesterol, and risk of future myocardial infarction: genomewideanalysis among 18 245 initially healthy women from theWomen's Genome Health Study. Circ. Cardiovasc. Genet., 2(1),26-33.
202. Bouatia-Naji, N.; Rocheleau, G.; Van Lommel, L.; Lemaire, K.;Schuit, F.; Cavalcanti-Proenca, C.; Marchand, M.; Hartikainen,A.L.; Sovio, U.; De Graeve, F.; Rung, J.; Vaxillaire, M.; Tichet, J.;Marre, M.; Balkau, B.; Weill, J.; Elliott, P.; Jarvelin, M.R.; Meyre,D.; Polychronakos, C.; Dina, C.; Sladek, R. and Froguel, P. (2008)A polymorphism within the G6PC2 gene is associated with fastingplasma glucose levels. Science, 320(5879), 1085-1088.
203. Rung, J.; Cauchi, S.; Albrechtsen, A.; Shen, L.; Rocheleau,G.; Cavalcanti-Proenca, C.; Bacot, F.; Balkau, B.; Belisle, A.;Borch-Johnsen, K.; Charpentier, G.; Dina, C.; Durand, E.; Elliott,P.; Hadjadj, S.; Jarvelin, M.R.; Laitinen, J.; Lauritzen, T.; Marre,M.; Mazur, A.; Meyre, D.; Montpetit, A.; Pisinger, C.; Posner, B.;Poulsen, P.; Pouta, A.; Prentki, M.; Ribel-Madsen, R.; Ruokonen,A.; Sandbaek, A.; Serre, D.; Tichet, J.; Vaxillaire, M.; Wojtaszewski,J.F.; Vaag, A.; Hansen, T.; Polychronakos, C.; Pedersen,O.; Froguel, P. and Sladek, R. (2009)Genetic variant near IRS1is associated with type 2 diabetes: insulin resistance and hyperinsulinemia.Nat. Genet., 41(10), 1110-1115.